Williams syndrome is a rare genetic neurodevelopmental disorder caused by a microdeletion on chromosome 7q11.23, presenting in infancy and childhood with supravalvular aortic stenosis, distinctive elfin facies, intellectual disability, hypercalcemia, and a characteristically overly friendly personality.

Exam domain	One-glance essentials
Definition / diagnosis	Contiguous-gene deletion syndrome at 7q11.23, including ELN ^[1] Combines cardiovascular disease with a distinctive cognitive-behavioural profile ^[1]
Epidemiology / risks	Usually de novo; affected individuals have 50% transmission risk ^[1] Recurrence is low unless a parent carries the deletion ^[1]
Core mechanism	Elastin haploinsufficiency causes arterial stenosis ^[1] Altered calcium regulation and neurodevelopment reflect other deleted genes ^[1]
Clinical picture	Elfin facies, overfriendliness, developmental delay and sound sensitivity ^[1] Supravalvular aortic stenosis and infantile hypercalcaemia are classic ^[1]
Investigations	Chromosomal microarray confirms the deletion ^[2] Assess blood pressure in all limbs, calcium, renal tract, hearing and thyroid ^[2]
Management	Cardiology-led treatment of vascular stenosis ^[3] Manage hypercalcaemia, development, anxiety and educational needs ^[3]
Complications	Sudden cardiac death, hypertension and progressive arterial stenosis ^[4] Nephrocalcinosis, hearing loss and endocrine problems ^[4]
Prevention / follow-up	Avoid unnecessary calcium/vitamin-D excess in hypercalcaemic children ^[3] Lifelong cardiovascular and renal surveillance ^[3]
Exam traps	*A friendly manner does not imply intact cognition or capacity* ^[2] Anaesthesia carries special risk in severe outflow obstruction ^[3]

References

^[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome)

^[2] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome)

^[3] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome)

^[4] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome)

Williams Syndrome (Williams-Beuren Syndrome)

Williams syndrome (WS), also known as Williams-Beuren syndrome, is a contiguous gene deletion syndrome caused by a hemizygous microdeletion on chromosome 7q11.23, encompassing approximately 26–28 genes including the critical elastin (ELN) gene ^[1]^[2]. The deletion spans approximately 1.5–1.8 Mb and results in a multisystem disorder characterised by a distinctive "elfin" facies, cardiovascular disease (especially supravalvular aortic stenosis), intellectual disability, a unique neurocognitive profile, hypercalcaemia, and a characteristic behavioural phenotype of overfriendliness ^[1]^[2]^[3].

Etymology / Name breakdown:

"Williams" — after Dr J.C.P. Williams (New Zealand cardiologist) who first described the syndrome in 1961

"Beuren" — after Dr Alois Beuren (German cardiologist) who independently described it in 1962

The condition is a microdeletion syndrome — "micro" = small, "deletion" = loss of genetic material; the deletion is too small to see on standard karyotype and requires FISH or chromosomal microarray for detection

High Yield Concept — Contiguous Gene Deletion

Williams syndrome is a classic example of a contiguous gene deletion syndrome — multiple adjacent genes are deleted together, producing a constellation of features. Each deleted gene contributes to different aspects of the phenotype. The elastin gene (ELN) deletion is responsible for the cardiovascular and connective tissue features, while other deleted genes (e.g., LIMK1, GTF2I, GTF2IRD1, CLIP2) contribute to the neurocognitive and behavioural profile ^[1]^[2].

Parameter	Detail
Incidence	~1 in 7,500–20,000 live births ^[1]^[2]
Sex ratio	M = F (no sex predilection) ^[1]
Inheritance	Majority de novo (~95%); autosomal dominant if inherited (rare) ^[1]^[2]
Recurrence risk	If parent affected: 50%; if de novo: < 5% (consider gonadal mosaicism)
Ethnic distribution	All ethnicities equally affected

In Hong Kong, the incidence is consistent with worldwide figures. Given HK's birth rate (~35,000–40,000 live births/year), approximately 2–5 new cases per year would be expected.
Because the majority are de novo deletions, there is usually no family history — the deletion arises as a new event during meiosis, specifically due to non-allelic homologous recombination (NAHR) between flanking low-copy repeats on chromosome 7.

The 7q11.23 region contains ~26–28 genes. Understanding which gene produces which feature is essential:

Gene	Normal Function	Consequence of Deletion
ELN (Elastin)	Encodes elastin — the major structural protein of arterial walls, skin, lungs, and connective tissue; provides elastic recoil	Supravalvular aortic stenosis, peripheral pulmonary stenosis, systemic arterial stenosis, renal artery stenosis, connective tissue laxity
LIMK1	LIM kinase 1 — involved in actin cytoskeleton remodelling in neurons; spatial processing	Visuospatial construction deficits
GTF2I / GTF2IRD1	General transcription factors — regulate gene expression in neural crest-derived tissues	Craniofacial dysmorphism ("elfin" facies), intellectual disability, hypersociability
CLIP2 (CYLN2)	Cytoplasmic linker protein — role in intracellular transport in neurons	Contributes to cognitive deficits
RFC2	DNA replication factor	Uncertain clinical significance
BAZ1B (WBSCR9)	Chromatin remodelling; regulates neural crest cell migration	May contribute to hypercalcaemia and craniofacial features
STX1A	Syntaxin 1A — involved in insulin secretion	May contribute to glucose metabolism abnormalities

3.1 Elastin — Why It Matters So Much

Elastin is the key structural protein in large and medium arteries. It is synthesised as tropoelastin by vascular smooth muscle cells, secreted into the extracellular space, and cross-linked into mature elastic fibres. In the aorta, elastin constitutes ~50% of the dry weight of the vessel wall.

Why does ELN haploinsufficiency cause supravalvular aortic stenosis?

With only one functional copy of ELN, there is ~50% reduction in elastin production
The arterial wall compensates by smooth muscle cell hyperplasia and increased collagen deposition
This makes the vessel wall thicker, stiffer, and narrowed — particularly at high-stress points like the sinotubular junction (just above the aortic valve), producing supravalvular aortic stenosis (SVAS)
The same process can affect any artery → generalised elastin arteriopathy

4. Aetiology and Pathophysiology

Caused by 7q11.23 deletion (involving the elastin gene) ^[1]
The deletion occurs due to non-allelic homologous recombination (NAHR) between low-copy repeat (LCR) sequences flanking the Williams-Beuren syndrome critical region (WBSCR)
These LCR blocks are highly homologous (~98% identical), making them prone to misalignment during meiosis → unequal crossing over → deletion on one chromosome (and duplication on the other — 7q11.23 duplication syndrome is a separate entity)

Majority de novo (~95%) ^[1]
Autosomal dominant if transmitted from an affected parent (50% risk to offspring)
Rarely, atypical deletions (smaller or larger than typical) produce partial phenotypes

4.2 Pathophysiology by System

Secondary to elastin arteriopathy involving any artery, occurs in 75% of patients ^[2].

Lesion	Mechanism	Clinical Significance
Supravalvular aortic stenosis (SVAS)	Elastin deficiency → smooth muscle hyperplasia at sinotubular junction → narrowing above aortic valve	Most common cardiovascular finding ^[2]^[3]; can be progressive; may cause LVH, heart failure
Peripheral pulmonary stenosis (PPS)	Same mechanism in pulmonary arterial branches	Common in infancy; often improves with age as pulmonary arteries grow ^[2]
Renal artery stenosis	Elastin arteriopathy of renal arteries	Can lead to secondary hypertension ^[2]
Coronary artery ostial stenosis	Thickening of aortic wall at coronary ostia → narrowed coronary origins	Risk of myocardial ischaemia and sudden death (especially during anaesthesia)
Systemic arterial stenosis	Any medium/large artery can be affected (coeliac, mesenteric, cerebral)	Generalised arterial hypertension

Critical Point — Sudden Cardiac Death Risk

Williams syndrome patients have an increased risk of sudden cardiac death, particularly during anaesthesia or sedation. This is due to:

Coronary artery ostial stenosis → myocardial ischaemia
Severe biventricular outflow tract obstruction (combined SVAS + PPS)
Arrhythmias secondary to myocardial hypertrophy

Always ensure cardiology review and echocardiography before any procedure requiring sedation/anaesthesia ^[2]^[3].

Characteristic elfin-like face ^[1] — the facial features result from abnormal neural crest cell development and connective tissue structure (due to loss of GTF2IRD1, GTF2I, and ELN):

Feature	Pathophysiological Basis
Broad forehead ^[2]	Altered craniofacial bone growth
Periorbital fullness of subcutaneous tissues ^[1]^[2]	Connective tissue abnormality
Short palpebral fissures ^[1]	Orbital development anomaly
Flat nasal bridge with anteverted nares ^[1]^[2]	Midface hypoplasia
Long philtrum ^[2]	Neural crest-derived tissue abnormality
Full/thick lips, wide mouth (usually held open) ^[1]^[2]	Connective tissue laxity and muscle tone
Small, widely spaced teeth (microdontia) ^[1]^[2]	Dental dysplasia; enamel hypoplasia, malocclusion, excessive interdental spacing ^[2]
Small chin (micrognathia) ^[1]	Mandibular hypoplasia
Prominent ears / prominent earlobes ^[1]^[2]	Cartilage/connective tissue
Blue eyes with stellate/starry iris pattern (~50%) ^[1]	Abnormal iris stromal development — a beautiful and distinctive sign
Round face with full cheeks ^[1]	Subcutaneous tissue and buccal fat pad
Flared eyebrows / medial eyebrow flare ^[1]

The facial features become more recognisable with age — in infancy, the face may appear round with periorbital fullness; by school age and adolescence, the "elfin" features are more pronounced, with coarsening of features.

Developmental delay and intellectual disability (~75%): usually mild-moderate ^[1]^[2]
- Mean IQ approximately 55–60 (range 40–90)
- Unique neurocognitive profile: relatively preserved language and auditory rote memory, with extreme deficits in visuospatial construction ^[2]
  - Why? The LIMK1 gene deletion specifically impairs dorsal stream visual processing ("where" pathway), affecting spatial reasoning, block design, and drawing tasks
  - Language is relatively spared because the neural substrates for language (left temporal-parietal regions) are less dependent on the deleted genes
- Hoarseness or low-pitched voice ^[2] — due to connective tissue changes in the larynx

Abnormal behaviour: over-friendly manner (happy/cocktail party personality) ^[1]

Feature	Mechanism
Overfriendliness / excessive empathy ^[1]^[2]	Loss of GTF2I → altered amygdala reactivity to social stimuli; reduced social inhibition
Anxiety / specific phobias ^[2]	Paradoxically, despite social disinhibition, there is increased generalised anxiety and noise phobia
Sleeping difficulties ^[2]	Altered melatonin metabolism; anxiety
Attention problems (ADHD) ^[2]	Executive function deficits
Hyperacusis ^[1]	Increased auditory sensitivity — may be related to altered auditory processing or middle ear anatomy; associated with specific phobias to loud noises

The 'Cocktail Party' Personality

Children with Williams syndrome are characteristically extremely sociable and gregarious — they approach strangers without fear, make intense eye contact, and show remarkable verbal fluency in social settings (hence "cocktail party personality"). However, this apparent social strength masks significant social vulnerability — they have difficulty reading social cues, forming deep friendships, and are at risk of exploitation. This overfriendliness is a red flag for the condition ^[1]^[2].

Feature	Mechanism
Transient neonatal hypercalcaemia (~15%) ^[1]; hypercalciuria (~30%) ^[2]	Possibly related to increased intestinal calcium absorption and/or altered vitamin D metabolism; BAZ1B deletion may play a role. Usually returns to normal by 12 months ^[1]. Associated with vomiting, feeding difficulties, constipation and prolonged colic ^[2]
Hypothyroidism (~10%) ^[1]^[2]	Mechanism not fully understood; may be subclinical; requires monitoring
Early puberty ^[1]	Altered hypothalamic-pituitary-gonadal axis

Short stature ^[1]^[2]; failure to thrive in infancy ^[2]
Growth delay ^[1]
Specific Williams syndrome growth charts exist (mean adult height ~10th percentile for general population)
Feeding difficulties in infancy are common (oral motor dysfunction, gastro-oesophageal reflux)

Renal artery stenosis ^[2]^[3] → secondary hypertension ^[2]
Congenital anomalies of kidney and urinary tract (CAKUT) ^[2] — e.g., renal agenesis, horseshoe kidney, vesicoureteral reflux
Renal anomalies ^[1]
Nephrocalcinosis (secondary to hypercalcaemia/hypercalciuria)

Kyphoscoliosis ^[1] — due to connective tissue laxity from elastin deficiency
Joint laxity in childhood → joint contractures in adulthood
Pes planus (flat feet)
Hypotonia in infancy

Hearing impairment: chronic otitis media, hyperacusis ^[1]
Sensorineural (high-tone) or conductive hearing loss ^[2]
Progressive sensorineural hearing loss may develop in adulthood

5. Classification

Williams syndrome does not have a formal subtype classification, but can be conceptualised along these axes:

Type	Deletion Size	Phenotype
Classic/Typical deletion (~95%)	~1.55 Mb	Full Williams syndrome phenotype
Larger atypical deletion	> 1.8 Mb	More severe intellectual disability; may have additional features
Smaller atypical deletion	< 1.5 Mb (partial deletion)	Partial phenotype — isolated SVAS if only ELN deleted

Pattern	Frequency
De novo	~95% ^[1]
Inherited (autosomal dominant)	~5% (from affected parent)
Gonadal mosaicism	Rare but important for genetic counselling

Isolated familial supravalvular aortic stenosis: Point mutations or small deletions of ELN only (without the full contiguous gene deletion) → isolated SVAS without the cognitive/behavioural phenotype
7q11.23 duplication syndrome: The reciprocal duplication produces a different phenotype — speech delay, autism-spectrum features, and social anxiety (essentially the "opposite" of the Williams behavioural phenotype)

6. Clinical Features

Symptom	Age of Presentation	Pathophysiological Basis
Feeding difficulties / poor weight gain	Neonatal / infancy	Oral motor dysfunction, hypotonia, GOR, hypercalcaemia-related vomiting
Vomiting, constipation, prolonged colic	Infancy	Hypercalcaemia ^[2] → decreased GI motility, increased renal concentration
Irritability / excessive crying	Infancy	Hypercalcaemia; hyperacusis causing distress from everyday sounds
Failure to thrive	Infancy – early childhood	Caloric insufficiency from feeding difficulties; possible endocrine factors
Developmental delay — late walking, late talking	Infancy – toddler	Mild-moderate intellectual disability ^[1]; hypotonia
Difficulty with drawing, puzzles, spatial tasks	Preschool onwards	Extreme visuospatial construction deficit ^[2] — LIMK1 deletion
"My child talks to everyone"	Toddler – school age	Overfriendliness / cocktail party personality ^[1]^[2]
Anxiety, phobias (especially noise phobia)	School age	Altered amygdala processing; hyperacusis ^[2]
Sleeping difficulties	Any age	Anxiety; melatonin dysregulation ^[2]
Attention problems	School age	ADHD ^[2]
Hearing concerns	Any age	Chronic otitis media; sensorineural hearing loss ^[1]^[2]
Shortness of breath / exercise intolerance	Depends on severity of cardiac disease	SVAS → LV pressure overload → LVH → reduced cardiac output
Chest pain (rare, ominous)	Any age	Coronary ostial stenosis → myocardial ischaemia
Polyuria / polydipsia	If hypercalcaemia significant	Hypercalcaemia → nephrogenic diabetes insipidus (Ca²⁺ interferes with aquaporin-2 in collecting duct)

6.2 Signs (What the Clinician Finds)

Sign	Detail	Basis
Short stature	Below 3rd-10th percentile for age	Growth delay; endocrine factors ^[1]
Elfin-like facies	See detailed table above	Neural crest / connective tissue ^[1]^[2]
Stellate iris pattern	Blue eyes with starry pattern (~50%) ^[1]	Iris stromal hypoplasia
Wide mouth usually held open	With thick/prominent lips ^[1]^[2]	Connective tissue laxity; low muscle tone
Small, widely spaced teeth	Microdontia, enamel hypoplasia ^[1]^[2]	Dental dysplasia
Hoarse or low-pitched voice	^[2]	Laryngeal connective tissue changes
Joint hypermobility (childhood)	Beighton score may be elevated	Elastin deficiency → connective tissue laxity

Sign	Detail	Basis
Ejection systolic murmur at right upper sternal border radiating to carotids	Supravalvular AS	Narrowing at sinotubular junction; turbulent flow through stenosis
Ejection systolic murmur at left upper sternal border radiating to back and axillae	Peripheral pulmonary stenosis	Multiple branch stenoses in pulmonary arterial tree
Blood pressure discrepancy (R arm > L arm)	If coarctation-like stenosis or aortic arch involvement	Arterial narrowing
Hypertension	May be present	Renal artery stenosis → secondary hypertension; or generalised elastin arteriopathy ^[2]
Pulse: may be low-volume with slow upstroke	Severe SVAS	Fixed obstruction to LV outflow

Supravalvular vs. Valvular Aortic Stenosis — Key Differences

In supravalvular AS (Williams syndrome), the narrowing is above the valve at the sinotubular junction. This has important consequences:

The coronary arteries arise below the stenosis, so they are exposed to high LV systolic pressure → coronary artery dilation, accelerated atherosclerosis, and ostial stenosis
There is no ejection click (unlike valvular AS where the thickened valve leaflets produce a click)
The murmur is loudest at the right upper sternal border and radiates to the neck/carotids
BP may be higher in the right arm (Coanda effect — the jet of blood through the stenosis preferentially enters the innominate/right subclavian artery)

Sign	Basis
Hypotonia (infancy)	Central hypotonia; connective tissue laxity
Hyperreflexia (older children/adults)	Upper motor neuron signs may develop
Poor fine motor coordination	Visuospatial deficits + motor planning difficulties
Relatively fluent speech (may appear more capable verbally than functionally)	Preserved language relative to visuospatial skills — the "cocktail party" verbal fluency

Sign	Basis
Inguinal/umbilical hernia	Connective tissue laxity
Rectal prolapse (rare)	Connective tissue laxity

Sign	Basis
Strabismus	Altered extraocular muscle/orbital development ^[2]
Hypertelorism	Midface structural anomaly ^[2]
Stellate iris	Iris stromal architecture

A useful mnemonic for remembering the features:

Letter	Feature
W	Wide mouth, friendly personality
I	Increased calcium (hypercalcaemia)
L	Long philtrum
L	Learning difficulties (mild-moderate ID)
I	Iris — stellate pattern
A	Aortic stenosis (supravalvular)
M	Mental retardation (prefer "intellectual disability")
S	Small stature / Small teeth

Understanding when features present helps with early recognition:

Age	Key Features
Neonate	Feeding difficulties, prolonged jaundice, transient hypercalcaemia, heart murmur (may not be detected yet), hypotonia
Infant (1–12 months)	Failure to thrive, irritability/colic (hypercalcaemia), peripheral pulmonary stenosis murmur, characteristic facies becoming apparent
Toddler (1–3 years)	Developmental delay (motor > language), elfin facies more recognisable, SVAS murmur now prominent, overfriendly behaviour emerging
Preschool (3–5 years)	Visuospatial deficits apparent on testing, cocktail party personality, ADHD/anxiety, hyperacusis
School age	Learning difficulties (especially maths, spatial reasoning), behavioural issues, hypertension may develop
Adolescence/Adult	Short stature, joint contractures replacing hypermobility, progressive SVAS, hypertension, diabetes mellitus, hearing loss, anxiety disorders

Parameter	Normal Range (Age-Dependent)	Relevance in WS
Serum calcium (total)	Neonate: 2.0–2.6 mmol/L; Child: 2.2–2.7 mmol/L	Hypercalcaemia (> 2.7 mmol/L) in ~15%
Serum ionised calcium	1.1–1.3 mmol/L	More accurate than total Ca
TSH	0.7–6.0 mIU/L (varies by age)	Hypothyroidism — elevated TSH
Free T4	10–26 pmol/L (varies by age)	Low in hypothyroidism
Blood pressure	Age-, sex-, height-specific percentiles (< 90th)	Hypertension if ≥ 95th percentile on 3 occasions

10. Growth and Development in Williams Syndrome

Prenatal growth: Usually normal
Postnatal growth: Failure to thrive in infancy; short stature throughout childhood
Specific Williams syndrome growth charts (Morris et al.) should be used — plotting on standard growth charts will show consistently low centiles
Mean adult height: approximately 10th percentile of general population (~152 cm females, ~164 cm males)

Gross motor: Delayed — mean walking age ~21 months (vs. normal 12–15 months); hypotonia contributes
Fine motor: Significantly delayed; visuospatial construction deficits are prominent
Language: Relatively preserved compared to other domains — may give a misleading impression of higher overall ability ("cocktail party speech"); vocabulary may be surprisingly good but comprehension is limited
Social: Overfriendliness and indiscriminate social approach — a diagnostic clue but also a safeguarding concern

Breaking the diagnosis: Parents often notice "something different" about the face or developmental progress. The diagnosis should be communicated sensitively, emphasising the child's strengths (sociability, verbal skills) while being honest about challenges.
Genetic counselling: Most cases are de novo — reassure parents about low recurrence risk (~< 5% due to potential gonadal mosaicism). If a parent is affected, recurrence risk is 50%.
Consent/Assent: For genetic testing and cardiac investigations, consent is obtained from parents/guardians. As the child matures, age-appropriate assent should be sought, recognising the intellectual disability.
Multidisciplinary team: Cardiologist, geneticist, developmental paediatrician, speech therapist, occupational therapist, dietitian, psychologist, audiologist, ophthalmologist, nephrologist, endocrinologist.

Williams syndrome is listed alongside 22q11.2 deletion syndrome, Loeys-Dietz syndrome, Marfan syndrome, Long QT syndrome, and Noonan syndrome as a "rare disease among common disease(s)" ^[5] — meaning these are rare genetic conditions that may initially present with common paediatric problems (e.g., heart murmur, developmental delay, short stature, feeding difficulties) before the unifying diagnosis is recognised.

GC Lecture High Yield — Rare Diseases Among Common Diseases

Williams syndrome should be considered in any child presenting with:

Supravalvular aortic stenosis (pathognomonic association)
Elfin facies + intellectual disability + overfriendliness
Hypercalcaemia in infancy
Peripheral pulmonary stenosis in a neonate/infant

The GC lecture groups it with other genetic syndromes with cardiac manifestations — know the cardiac associations for each syndrome ^[5]:

Down syndrome → AVSD, VSD
Turner syndrome → Coarctation, bicuspid aortic valve
Williams syndrome → Supravalvular AS, peripheral PS ^[3]
Noonan syndrome → Valvular PS, HCM
DiGeorge (22q11.2 deletion) → Conotruncal defects (interrupted aortic arch, truncus arteriosus, ToF)

High Yield Summary

Williams Syndrome — Key Facts for Exams:

7q11.23 microdeletion including the elastin (ELN) gene — majority de novo ^[1]^[2]
Elfin facies: broad forehead, periorbital fullness, flat nasal bridge, anteverted nares, long philtrum, full lips, wide mouth, small widely spaced teeth, prominent ears, stellate iris ^[1]^[2]
Supravalvular aortic stenosis — most common and most characteristic cardiac lesion ^[2]^[3]
Peripheral pulmonary stenosis — common in infancy, often improves ^[2]
Elastin arteriopathy → any artery can be affected → renal artery stenosis → hypertension ^[2]^[3]
Coronary ostial stenosis → risk of sudden cardiac death (especially under anaesthesia)
Intellectual disability (75%, mild-moderate) with characteristic profile: preserved language, extreme visuospatial deficit ^[1]^[2]
Overfriendly / "cocktail party" personality — pathognomonic behavioural phenotype ^[1]^[2]
Hypercalcaemia (~15%) — transient neonatal, causes feeding difficulties and colic; hypercalciuria (~30%) ^[1]^[2]
Hypothyroidism (~10%) ^[1]^[2]; early puberty ^[1]
Short stature / failure to thrive ^[1]^[2]
Hyperacusis and sensorineural/conductive hearing loss ^[1]^[2]
Diagnosis by FISH or chromosomal microarray (CMA) — not visible on standard karyotype
Associations to remember: WILLIAMS = Wide mouth, Increased Ca²⁺, Long philtrum, Learning difficulties, Iris (stellate), Aortic stenosis (supravalvular), Mental retardation, Small stature/teeth

Active Recall - Williams Syndrome (Definition, Epidemiology, Aetiology, Pathophysiology, Clinical Features)

^[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome) ^[2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) ^[3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) ^[4] Lecture slides: CFB (PAE02) Child growth and development.pdf ^[5] Lecture slides: GC 151. The malformed child hereditary syndromes and anomalies.pdf (p. 36 — Rare diseases among common diseases)

Differential Diagnosis of Williams Syndrome

Williams syndrome rarely presents as a neat diagnostic label on first encounter. Instead, a child presents with one or more of its cardinal features — and each feature has its own differential diagnosis. The clinician's job is to recognise the pattern that unifies these features and distinguishes Williams from its mimics.

The key presenting problems that trigger a differential include:

A dysmorphic child (elfin facies + intellectual disability)
A heart murmur / congenital heart disease (especially supravalvular aortic stenosis)
Hypercalcaemia in infancy
Short stature / failure to thrive
Developmental delay with a distinctive neurocognitive/behavioural profile
Hypertension in a child

We will work through the differential from each of these "entry points," then bring them together.

1. Differential Diagnosis by Presenting Feature

This is the most common exam framing: you see a child with distinctive facies + developmental delay + congenital heart disease and must identify the syndrome. The GC lecture "The malformed child: hereditary syndromes and anomalies" ^[5] explicitly groups Williams syndrome with other "rare diseases among common disease(s)" — conditions that may initially present with common paediatric problems before a unifying syndromic diagnosis is recognised.

GC Lecture High Yield — Syndrome–Cardiac Defect Associations

This table is directly examinable. The GC lecture ^[5] and multiple senior notes ^[1]^[3]^[6] emphasise syndrome-cardiac associations. Know the dysmorphic features AND the characteristic cardiac lesion for each syndrome.

Syndrome	Genetics	Key Dysmorphic Features	Characteristic Cardiac Defect	Distinguishing Feature from WS
Williams syndrome ^[1]^[2]^[3]^[6]	7q11.23 deletion (elastin gene)	Elfin facies, stellate iris, full lips, wide mouth, periorbital fullness	Supravalvular AS, peripheral PS	— (this is the index condition)
Down syndrome ^[1]^[3]	Trisomy 21	Upslanting palpebral fissures, epicanthic folds, flat nasal bridge, protruding tongue, brachycephaly, single palmar crease	AVSD, VSD, ASD, PDA, ToF	Hypotonia, Brushfield spots; no hypercalcaemia; global delay without the visuospatial/verbal dissociation
Noonan syndrome ^[1]^[3]^[6]	RASopathy (PTPN11, etc.)	Turner-like but normal karyotype, both sexes; ptosis, downslanting palpebral fissures, low-set ears, webbed neck, shield chest	Valvular PS (dysplastic valve), HCM	Right-sided cardiac lesions (vs. WS which is arterial stenosis); cryptorchidism in males; bleeding tendency
Turner syndrome ^[1]^[3]	45,X	Short stature, webbed neck, low hairline, cubitus valgus, widely spaced nipples	Left-sided: Coarctation of aorta, bicuspid aortic valve	Females only; lymphoedema in neonates; streak gonads; no hypercalcaemia, no overfriendliness
DiGeorge syndrome (22q11.2 deletion) ^[1]^[3]^[5]	22q11.2 deletion	Low-set posteriorly rotated ears, hypertelorism, cleft palate, thymic hypoplasia	Conotruncal defects: interrupted aortic arch, truncus arteriosus, ToF	Hypocalcaemia (opposite of WS which has hyper-Ca²⁺ — because DiGeorge involves parathyroid hypoplasia → ↓PTH); immune deficiency
Marfan syndrome ^[5]^[6]	FBN1 mutation	Tall stature, arachnodactyly, joint hypermobility, high-arched palate, ectopia lentis	MVP, AR, aortic root dilation	Tall stature (WS is short); lens dislocation upward; normal intelligence; connective tissue laxity but different mechanism (fibrillin-1 vs. elastin)
Fragile X syndrome ^[6]	FMR1 CGG repeat expansion (X-linked)	Long face, large ears, prominent mandible, macrocephaly	MVP (minor)	Macro-orchidism post-puberty; most common genetic cause of learning difficulties; autism features; no hypercalcaemia
Foetal alcohol spectrum disorder (FASD)	Prenatal alcohol exposure	Smooth philtrum, thin vermillion border, short palpebral fissures, midface hypoplasia	VSD, ASD, ToF	Maternal alcohol history; no hypercalcaemia; microcephaly; growth restriction prenatal + postnatal
Loeys-Dietz syndrome ^[5]	TGFBR1/TGFBR2 mutations	Hypertelorism, bifid uvula/cleft palate, arterial tortuosity	Aortic root aneurysm, arterial aneurysms	Aggressive arterial aneurysm formation (vs. arterial stenosis in WS); bifid uvula is pathognomonic
Costello syndrome	HRAS mutation (RASopathy)	Coarse facies, redundant skin, curly hair, deep palmar creases	PS, HCM	Papillomata; increased malignancy risk; coarse facies distinct from elfin

Key distinguishing principle: Williams syndrome produces arterial stenosis (especially supravalvular aortic stenosis) — this is virtually pathognomonic. If you see supravalvular AS in a child, think Williams syndrome first. No other common syndrome produces this specific lesion.

Supravalvular aortic stenosis (SVAS) is the most common cardiovascular finding in Williams syndrome ^[2]. However, SVAS can also occur in:

Cause	Mechanism	How to Differentiate
Williams syndrome	ELN haploinsufficiency → diffuse elastin arteriopathy	Elfin facies, ID, hypercalcaemia, overfriendliness — multisystem
Familial (isolated) SVAS	Point mutations or small intragenic deletions of ELN only	Autosomal dominant inheritance; SVAS without dysmorphism, without cognitive/behavioural features; family history of SVAS
Homozygous familial hypercholesterolaemia	Severe atherosclerosis affecting aortic root	Xanthomata; very high LDL; onset in older childhood/teens
Post-surgical (e.g., after arterial switch for TGA)	Scarring/fibrosis at surgical anastomosis site	History of cardiac surgery
Rubella embryopathy	Viral-induced arteritis during fetal development	Cataracts, deafness, PDA; maternal rubella history

Transient neonatal hypercalcaemia (~15%) ^[1] is an important early clue to Williams syndrome. The DDx of neonatal/infantile hypercalcaemia includes:

Cause	Mechanism	Distinguishing Features
Williams syndrome	Possibly ↑ intestinal Ca²⁺ absorption; altered vitamin D sensitivity; BAZ1B deletion	Elfin facies, SVAS, transient (resolves by ~12 months ^[1])
Idiopathic infantile hypercalcaemia (IIH)	CYP24A1 mutations → impaired inactivation of 1,25(OH)₂D	No dysmorphism; persistent or recurrent; genetic testing distinguishes
Primary hyperparathyroidism	PTH-secreting adenoma or neonatal severe hyperparathyroidism (NSHPT from homozygous CaSR mutation)	Very high PTH; NSHPT presents neonatally with severe hypercalcaemia
Subcutaneous fat necrosis	Activated macrophages in necrotic fat produce 1,25(OH)₂D	History of birth trauma/hypothermia; firm subcutaneous nodules
Vitamin D intoxication	Excessive supplementation → ↑ Ca²⁺ absorption	Medication history; very high 25(OH)D levels
Phosphate depletion	e.g., in preterm infants on phosphate-poor feeds	Premature infant; low serum phosphate
Familial hypocalciuric hypercalcaemia (FHH)	Heterozygous loss-of-function CaSR mutation → ↑ renal Ca²⁺ reabsorption	Mild hypercalcaemia, low urinary Ca²⁺ excretion, benign; autosomal dominant
Malignancy	PTHrP secretion (rare in infants)	Tumour evident on imaging

Condition	Key Distinguishing Feature
Williams syndrome	Elfin facies, SVAS, hypercalcaemia, overfriendliness
Turner syndrome	Females only, webbed neck, coarctation, streak gonads
Noonan syndrome	Both sexes, valvular PS/HCM, cryptorchidism, bleeding tendency
Down syndrome	Characteristic facies, AVSD, hypotonia
Russell-Silver syndrome	Hemihypertrophy, triangular face, limb asymmetry, normal head size relative to body, clinodactyly — NO cardiac defect typically
Growth hormone deficiency	Proportionate short stature, no dysmorphism, delayed bone age
Constitutional delay	Normal variant, positive family history, delayed bone age, eventually reaches normal height

The "cocktail party" personality is relatively specific to Williams syndrome, but overfriendly behaviour can also be seen in:

Condition	How It Differs from WS
Angelman syndrome (15q11.2 deletion, maternal)	"Happy puppet" — frequent laughter, hand-flapping, ataxic gait, severe ID, seizures; no SVAS or hypercalcaemia
ADHD (isolated)	No dysmorphism, no cardiac disease, no hypercalcaemia
Autism spectrum disorder (paradox)	Children with WS are often excessively social (opposite of classic ASD); however, social cognition is impaired in both — just manifested differently
Foetal alcohol spectrum disorder	Smooth philtrum, thin upper lip; maternal alcohol history

Renal artery stenosis → secondary hypertension ^[2] is an important complication of Williams syndrome. In a child with hypertension:

Cause	Clue
Williams syndrome (renal artery stenosis / generalised elastin arteriopathy) ^[2]^[3]	Elfin facies, SVAS, known WS diagnosis
Renal parenchymal disease (GN, reflux nephropathy, CKD)	Abnormal urinalysis, ↑ creatinine, small/scarred kidneys on US
Coarctation of aorta	Diminished and delayed femoral pulses, reduced femoral BP ^[7]; upper-lower limb BP gradient
Phaeochromocytoma	Paroxysmal hypertension, headaches, sweating; skin stigmata of neurofibromatosis ^[7]
Conn syndrome / adrenal hyperplasia	Hypokalaemia
Cushing syndrome	Cushing facies, striae, central obesity ^[7]
Essential hypertension	Older child/adolescent, obese, family history; most common cause in adolescents
Fibromuscular dysplasia	Young female; renal bruit; "string of beads" on angiography

The following mermaid diagram illustrates how a clinician moves from the presenting feature to the correct syndromic diagnosis:

A very useful clinical pearl in the paediatric syndrome DDx is the direction of calcium abnormality:

Syndrome	Calcium	Why
Williams syndrome	Hypercalcaemia ↑	Altered vitamin D metabolism / intestinal absorption (BAZ1B and related genes)
DiGeorge syndrome (22q11.2 deletion)	Hypocalcaemia ↓	Parathyroid hypoplasia → ↓PTH → ↓Ca²⁺
Down syndrome	Usually normal	No specific calcium disturbance
Noonan syndrome	Usually normal	No specific calcium disturbance
Turner syndrome	Usually normal	No specific calcium disturbance

Exam Pearl — Hyper- vs. Hypocalcaemia in Syndromic DDx

If an OSCE or written paper gives you a dysmorphic child with a heart murmur and hypercalcaemia → think Williams syndrome (SVAS). If the same child has hypocalcaemia → think DiGeorge (22q11.2 deletion) (conotruncal defects). The calcium direction is a quick discriminator between two commonly tested syndromes ^[1]^[2]^[3].

WS Feature	Other Conditions Sharing This Feature	Key Differentiator
Supravalvular AS	Familial isolated SVAS, rubella embryopathy, homozygous FH	Only WS has the full constellation of elfin facies + ID + behavioural phenotype
Peripheral pulmonary stenosis	Noonan syndrome, Alagille syndrome, congenital rubella	Alagille has bile duct paucity + butterfly vertebrae + posterior embryotoxon; Noonan has dysplastic valvular PS
Hypercalcaemia (infantile)	IIH (CYP24A1), subcutaneous fat necrosis, vitamin D excess, FHH, NSHPT	Only WS has the associated facies + cardiac lesion
Overfriendly behaviour	Angelman syndrome, ADHD	Angelman has severe ID, seizures, absent speech, ataxia; ADHD has no dysmorphism
Stellate iris	Relatively specific to WS	Very useful "spot diagnosis" sign
Elfin facies	Leprechaunism (Donohue syndrome — severe insulin resistance)	Leprechaunism has severe IUGR, lipoatrophy, hyperinsulinism
Short stature + ID	Many syndromes — non-specific	Must use the pattern of associated features to differentiate

Feature	Williams	Down	Noonan	Turner	DiGeorge
Genetics	7q11.23 del	Trisomy 21	RASopathy	45,X	22q11.2 del
Facies	Elfin	Flat, upslanting	Turner-like, ptosis	Webbed neck	Low-set ears, cleft
Cardiac	Supravalvular AS	AVSD	Valvular PS, HCM	Coarctation	Conotruncal
Calcium	↑ Hyper	Normal	Normal	Normal	↓ Hypo
Behaviour	Overfriendly	Generally amiable	Variable	Normal	Psychiatric risk
Immune	Normal	↑ Leukaemia risk	Normal	Normal	T-cell deficiency
Sex	M = F	M = F	M = F	F only	M = F
Stature	Short	Short	Short	Short	Variable

When facing a child with suspected Williams syndrome or any syndromic diagnosis:

Pattern recognition — Do the facial features fit? (elfin facies = Williams; flat face + upslanting fissures = Down; webbed neck = Turner/Noonan)
Cardiac lesion type — The single most discriminating feature in the syndrome-cardiac association table
Calcium level — Hypercalcaemia (Williams) vs. hypocalcaemia (DiGeorge)
Behavioural phenotype — Overfriendliness is highly suggestive of Williams
Confirm genetically — FISH or chromosomal microarray for 7q11.23 deletion

High Yield Summary — Differential Diagnosis of Williams Syndrome

When to suspect Williams syndrome over mimics:

Supravalvular AS is virtually pathognomonic — no other common syndrome produces it ^[2]^[3]
Elfin facies + hypercalcaemia + overfriendliness = Williams until proven otherwise ^[1]^[2]
Calcium direction distinguishes WS (↑Ca²⁺) from DiGeorge (↓Ca²⁺)
Cardiac lesion type distinguishes all major syndromes: SVAS = Williams, AVSD = Down, valvular PS = Noonan, coarctation = Turner, conotruncal = DiGeorge ^[1]^[3]^[5]^[6]
The GC lecture groups Williams with 22q11.2 deletion, Marfan, Noonan, Loeys-Dietz, and Long QT as "rare diseases among common diseases" ^[5] — know all their cardiac associations
Familial isolated SVAS (ELN point mutations) is the closest genetic differential — same cardiac lesion but no dysmorphism, cognitive, or behavioural features

Active Recall - Differential Diagnosis of Williams Syndrome

References

^[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 184, 514 — Williams Syndrome, Syndromic cardiac associations) ^[2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) ^[3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) ^[5] Lecture slides: GC 151. The malformed child hereditary syndromes and anomalies.pdf (p. 36 — Rare diseases among common diseases) ^[6] Senior notes: Maksim Paediatric Notes.pdf (p. 206 — Williams syndrome, Noonan syndrome, Marfan syndrome, Fragile X) ^[7] Senior notes: Block A - High blood pressure_ hypertension.pdf (p. 25 — Secondary hypertension physical exam features)

Diagnostic Criteria, Diagnostic Algorithm, and Investigations for Williams Syndrome

1. Diagnostic Criteria

Williams syndrome does not have a formal points-based diagnostic scoring system (unlike, say, the revised Jones criteria for rheumatic fever). Instead, diagnosis relies on:

Clinical suspicion based on pattern recognition of cardinal features
Confirmation by genetic testing demonstrating the 7q11.23 deletion ^[1]^[2]

The diagnosis is therefore a two-step process: clinical recognition → genetic confirmation.

A clinical diagnosis of Williams syndrome should be suspected when ≥ 2 of the following cardinal features are present in a child:

Cardinal Feature	Frequency	Detail
Characteristic "elfin" facies	~100% (becomes more recognisable with age)	Broad forehead, periorbital fullness, flat nasal bridge, anteverted nares, long philtrum, full lips, wide mouth, small widely spaced teeth, prominent ears, small chin ^[1]^[2]
Cardiovascular disease — especially supravalvular aortic stenosis	~75% ^[1]^[2]^[3]	SVAS is the most common cardiovascular finding; also peripheral pulmonary stenosis, renal artery stenosis, coronary ostial stenosis ^[2]^[3]
Intellectual disability / developmental delay	~75% ^[1]^[2]	Usually mild-moderate; characteristic profile with preserved language but extreme visuospatial construction deficit ^[2]
Hypercalcaemia	~15% (hypercalciuria ~30%) ^[1]^[2]	Transient neonatal hypercalcaemia; usually returns to normal by 12 months ^[1]; causes vomiting, feeding difficulties, constipation, prolonged colic ^[2]
Characteristic behavioural phenotype	Very common	Over-friendly manner / "cocktail party" personality, excessive empathy, anxiety, specific phobias, ADHD ^[1]^[2]
Connective tissue abnormalities	Common	Joint laxity (childhood), hoarse voice, inguinal hernia, kyphoscoliosis ^[1]
Growth failure / short stature	Common	Failure to thrive in infancy; short stature throughout ^[1]^[2]
Stellate iris pattern	~50% ^[1]	Virtually pathognomonic when present in combination with other features

Key Principle — Why There Are No Strict Diagnostic Criteria

Williams syndrome is diagnosed by genetic testing, not by a clinical score. The clinical features raise suspicion, but the confirmatory test is FISH or chromosomal microarray (CMA) demonstrating hemizygous deletion of the WBSCR at 7q11.23 ^[1]^[2]. This is because:

The phenotype varies in severity — some patients have subtle features
Atypical deletions (smaller or larger) produce partial phenotypes
No single clinical feature is 100% specific (though SVAS + elfin facies is highly suggestive)

Williams syndrome is genetically confirmed when:

A hemizygous deletion at chromosome 7q11.23, encompassing the Williams-Beuren syndrome critical region (WBSCR) including the elastin (ELN) gene, is demonstrated by FISH, chromosomal microarray, or MLPA. ^[1]^[2]

The following algorithm represents the clinical approach from initial suspicion to confirmed diagnosis and systematic evaluation of complications.

2.1 Step-by-Step Walkthrough of the Algorithm

Step 1 — Clinical Suspicion

A paediatric geneticist, cardiologist, or general paediatrician notices one or more cardinal features
The most common triggers are:
- Neonatologist: heart murmur in a newborn + feeding difficulties + hypercalcaemia
- Cardiologist: echocardiographic finding of supravalvular AS → "Is this Williams?"
- Developmental paediatrician: a child with developmental delay + elfin facies + overfriendly behaviour
- General paediatrician: failure to thrive + dysmorphic features

Step 2 — Clinical Assessment

Systematic dysmorphology examination looking for the cardinal features (facies, growth, behaviour)
Cardiac auscultation and blood pressure measurement
Developmental assessment

Step 3 — Genetic Confirmation

If ≥ 2 cardinal features are present → order genetic testing
If only 1 feature is present but it is highly specific (e.g., SVAS with suggestive facies) → still reasonable to test

Step 4 — Systematic Evaluation

Once the diagnosis is confirmed, a comprehensive baseline work-up is required to identify all affected organ systems and guide long-term follow-up (see Section 3 below)

3. Investigation Modalities — Detailed Guide

Test	Principle	What It Shows	Key Findings in WS	Limitations
FISH (Fluorescence In-Situ Hybridisation)	A fluorescently labelled DNA probe complementary to the ELN gene region is hybridised to patient's metaphase chromosomes. Normal: 2 signals (one per chromosome 7). WS: only 1 signal (hemizygous deletion).	Presence or absence of the target region	Only 1 signal at 7q11.23 (confirms hemizygous deletion)	Cannot detect atypical/smaller deletions outside the probe target; cannot detect point mutations; requires dividing cells (metaphase spread)
Chromosomal Microarray (CMA)	Array comparative genomic hybridisation (aCGH) or SNP array — scans the entire genome for copy number variations (CNVs) at high resolution	Genome-wide CNV detection with precise breakpoint mapping	1.5–1.8 Mb deletion at 7q11.23	More expensive than FISH; may find variants of uncertain significance (VUS) elsewhere
MLPA (Multiplex Ligation-dependent Probe Amplification)	Multiple probes targeting specific exons within the WBSCR are used; relative probe signal quantifies copy number	Detects deletions/duplications of individual genes within WBSCR	Confirms deletion and can detect atypical/smaller deletions missed by standard FISH	Does not detect balanced rearrangements
Standard Karyotype	G-banded chromosomal analysis at ~5–10 Mb resolution	Gross chromosomal abnormalities	Normal — the 7q11.23 deletion (~1.5 Mb) is too small to be visible on standard karyotype	Cannot diagnose Williams syndrome — this is why FISH or CMA is required

Why Standard Karyotype Misses Williams Syndrome

A common mistake is to think that a "normal karyotype" excludes a genetic syndrome. The 7q11.23 deletion in Williams syndrome is a microdeletion (~1.5 Mb), well below the ~5–10 Mb resolution of G-banded karyotyping. You must request FISH for ELN/WBSCR or chromosomal microarray specifically. In current clinical practice (2025–2026), CMA is increasingly the first-line genetic test for children with unexplained developmental delay + dysmorphism, as it can detect Williams and many other microdeletion/microduplication syndromes in a single assay.

Which test to order first?

If high clinical suspicion for Williams syndrome specifically (classic facies + SVAS) → FISH for 7q11.23 is fast, targeted, and relatively inexpensive
If the presentation is non-specific (developmental delay + dysmorphism but the specific syndrome is unclear) → CMA is preferred as a "catch-all" first-line test that screens for many microdeletion syndromes simultaneously
Current American College of Medical Genetics (ACMG) and American Academy of Pediatrics (AAP) guidelines recommend CMA as the first-tier genetic test for children with unexplained intellectual disability, developmental delay, or multiple congenital anomalies

Cardiac involvement occurs in ~75% of patients ^[1]^[2]^[3] — cardiovascular evaluation is mandatory at diagnosis and requires ongoing surveillance.

Investigation	What It Assesses	Key Findings in WS	Why It Matters
Echocardiography (transthoracic)	Cardiac anatomy, valve function, ventricular function, great vessel morphology	Supravalvular aortic stenosis (narrowing at sinotubular junction); peripheral pulmonary stenosis; LV hypertrophy; coronary artery ostial narrowing (difficult to visualise on TTE)	Gold standard for identifying and quantifying the severity of SVAS and PS; guides need for intervention
Four-limb blood pressure measurement	Assesses for arterial stenosis and coarctation-like physiology	Hypertension (any limb); BP discrepancy between arms (Coanda effect in SVAS → right arm BP may be higher); upper vs. lower limb gradient if aortic arch involvement	Detects systemic hypertension (from renal artery stenosis ^[2] or generalised arteriopathy); must use age-, sex-, and height-appropriate paediatric BP percentile tables
ECG (12-lead)	Rhythm, axis, chamber hypertrophy, ST-T changes	LV hypertrophy (tall R waves in V5-V6, deep S waves in V1-V2); biventricular hypertrophy if combined SVAS + PS; ST-T changes if myocardial ischaemia (from coronary ostial stenosis)	Baseline and surveillance; important pre-anaesthetic assessment
Cardiac catheterisation / angiography	Precise haemodynamic assessment; coronary artery anatomy	Gradient across SVAS; pulmonary artery pressures; coronary artery ostial stenosis (best visualised on aortogram)	Reserved for pre-surgical planning or when echocardiography is inadequate; carries procedural risk
CT angiography / MR angiography	Non-invasive vascular imaging	Detailed anatomy of SVAS, aortic arch, branch pulmonary arteries, renal arteries, other systemic arteries	Useful for mapping extent of elastin arteriopathy throughout the body; renal artery stenosis assessment

Interpreting the echocardiogram — Supravalvular AS grading:

Severity	Peak Gradient	Clinical Significance
Mild	< 25 mmHg	Observation; annual echo
Moderate	25–50 mmHg	Closer follow-up (6-monthly); consider surgery if progressive
Severe	> 50 mmHg	Surgical intervention usually required (patch aortoplasty or resection)

Note on paediatric BP interpretation: Normal BP in children is defined by age-, sex-, and height-specific percentile tables. Hypertension = systolic and/or diastolic BP ≥ 95th percentile on ≥ 3 separate occasions. In Williams syndrome, always consider renal artery stenosis ^[2] as the cause of any hypertension found.

Investigation	What It Assesses	Key Findings in WS	Interpretation
Serum total and ionised calcium	Calcium homeostasis	Hypercalcaemia (~15%) ^[1]^[2]; may be transient (neonatal) or persistent	Total Ca > 2.7 mmol/L in infants (corrected for albumin); ionised Ca > 1.35 mmol/L is more reliable. Usually returns to normal by 12 months ^[1]; persistent hypercalcaemia warrants further work-up
Urine calcium:creatinine ratio	Urinary calcium excretion	Hypercalciuria (~30%) ^[2]	Normal paediatric UCa:Cr ratio < 0.6 (infants) or < 0.2 (children > 2 years); elevated in WS even when serum Ca normalises
Serum phosphate, ALP, 25(OH)D, 1,25(OH)₂D, PTH	Differentiating cause of hypercalcaemia	PTH usually low-normal or suppressed (because hypercalcaemia suppresses PTH); vitamin D metabolites may be elevated	Helps exclude primary hyperparathyroidism (PTH would be elevated); excludes vitamin D intoxication (25(OH)D very high)
TSH and free T4	Thyroid function	Hypothyroidism (~10%) ^[1]^[2] — subclinical (elevated TSH, normal fT4) or overt	Screen at diagnosis and annually; paediatric reference ranges vary by age
Fasting glucose / HbA1c	Glucose metabolism	Impaired glucose tolerance / diabetes mellitus (more common in adolescents/adults with WS)	Emerges with age; STX1A deletion may contribute
Renal function (urea, creatinine, eGFR)	Kidney function	May be abnormal if renal anomalies or nephrocalcinosis	Use paediatric creatinine reference ranges (Schwartz formula for eGFR in children)

Investigation	What It Assesses	Key Findings in WS	Why
Renal ultrasound	Renal anatomy, size, echogenicity, collecting system	CAKUT ^[2] — horseshoe kidney, renal agenesis, duplex system, vesicoureteral reflux; nephrocalcinosis (from hypercalciuria)	Baseline imaging at diagnosis; non-invasive
Doppler ultrasound of renal arteries	Renal artery blood flow velocity	Renal artery stenosis ^[2]^[3] — elevated peak systolic velocity, tardus-parvus waveform in intrarenal arteries	Screening for renovascular hypertension; if abnormal → consider CTA/MRA for confirmation
Urinalysis	Proteinuria, haematuria	May show proteinuria if renal parenchymal involvement	Baseline screening

Assessment	What It Measures	Expected Findings in WS
Developmental screening (e.g., Griffiths, Bayley)	Overall developmental quotient across domains	Developmental delay — motor > language; global but with characteristic dissociation
IQ testing (e.g., WISC at school age)	Full-scale, verbal, and performance IQ	Mean IQ ~55–60 (range 40–90); verbal IQ > performance IQ (because language is relatively preserved while visuospatial skills are profoundly impaired) ^[2]
Specific visuospatial testing (e.g., block design, Rey-Osterrieth complex figure)	Visuospatial construction	Extreme deficit ^[2] — drawings show poor spatial organisation, fragmented copying
Adaptive behaviour assessment (e.g., Vineland)	Functional daily living skills	Lower than would be predicted by verbal ability alone — the "cocktail party" verbal fluency masks functional impairment
Behavioural assessment (e.g., CBCL, Conners for ADHD)	Behavioural/emotional profile	Overfriendliness, anxiety, specific phobias, ADHD, sleeping difficulties ^[1]^[2]

Test	What It Measures	Expected Findings
Brainstem evoked response audiometry (BERA) / OAE (infants)	Hearing thresholds; cochlear and neural function	Sensorineural hearing loss (high-frequency) ^[2]; or conductive loss from chronic otitis media ^[1]
Pure tone audiometry (older children)	Frequency-specific hearing thresholds	High-tone sensorineural loss; may be progressive
Tympanometry	Middle ear function	Type B tympanogram if middle ear effusion (chronic OM)
Hyperacusis questionnaire	Sensitivity to sound	Hyperacusis ^[1] is common and may cause significant distress

Test	What It Measures	Expected Findings
Slit-lamp examination	Iris and anterior segment	Stellate / starry iris pattern (~50%) ^[1]
Visual acuity testing	Refractive errors	Hypermetropia (far-sightedness) is common
Cover-uncover test / Hirschberg	Strabismus	Strabismus ^[2]
Fundoscopy	Retina, optic disc	Usually normal; screen for hypertensive retinopathy if hypertensive

Investigation	Indication	Expected Findings
Spinal radiograph	If clinical concern for scoliosis	Kyphoscoliosis ^[1]
Bone age (left wrist X-ray)	Short stature evaluation	May be delayed
Dental assessment	Dental anomalies	Microdontia, enamel hypoplasia, excessive interdental spacing, malocclusion ^[2]

Once the diagnosis is genetically confirmed, a systematic baseline evaluation should be performed. Think of this as screening every organ system that Williams syndrome can affect:

System	Baseline Investigation	Frequency of Surveillance
Cardiovascular	Echocardiogram, ECG, 4-limb BP	Echo: 6-monthly to annually (more frequent if moderate-severe lesion); BP: every visit
Endocrine — Calcium	Serum Ca²⁺ (total + ionised), urine Ca:Cr ratio	Every 6 months in infancy; annually thereafter; more often if abnormal
Endocrine — Thyroid	TSH + fT4	Annually from diagnosis
Renal	Renal US + Doppler, RFT, urinalysis	At diagnosis; repeat if hypertension or abnormal
Growth	Height, weight, HC plotted on WS-specific growth charts	Every visit
Development	Formal developmental assessment	At diagnosis; regular follow-up with developmental paediatrician
Audiology	BERA/OAE (infants); PTA (older children)	At diagnosis; annually or if concerns
Ophthalmology	Visual acuity, slit-lamp, strabismus screen	At diagnosis; annually
Dental	Dental examination	From eruption of first teeth; regular dental follow-up
Musculoskeletal	Clinical assessment for scoliosis, joint laxity	Every visit
Behavioural / Psychiatric	Behavioural assessment, screen for anxiety/ADHD	Ongoing; formal assessment at school entry

5. Interpreting Key Investigation Results — Clinical Scenarios

Interpretation: Supravalvular aortic stenosis — narrowing at the sinotubular junction, not at the valve itself
How this differs from valvular AS: No thickened/calcified valve leaflets; no ejection click on auscultation; the stenosis is a discrete or diffuse hourglass narrowing above the valve
Clinical significance: Grade the severity by peak gradient; if moderate-severe → cardiology follow-up, consider surgical repair
Why coronary arteries are at risk: The coronaries originate below the stenosis and are exposed to high LV systolic pressure → ostial stenosis, dilation, accelerated atherosclerosis → risk of myocardial ischaemia and sudden cardiac death

Interpretation: Neonatal hypercalcaemia — this is a recognised feature of WS (~15% ^[1])
Next steps: Check ionised Ca²⁺ (more accurate), PTH (expected low/suppressed), 25(OH)D, 1,25(OH)₂D, urine Ca:Cr ratio
Management: Low-calcium formula, avoid vitamin D supplementation, monitor closely; usually resolves by 12 months ^[1]
If persistent: Investigate for other causes (CYP24A1 mutation, primary hyperparathyroidism)

Interpretation: This is hypertension (> 95th percentile for age/sex/height)
Most likely cause: Renal artery stenosis ^[2] due to elastin arteriopathy
Next steps: Repeat BP on 3 occasions to confirm; Doppler US of renal arteries; if suggestive → CTA or MRA for confirmation
Treatment: ACE inhibitors or ARBs if renal artery stenosis is unilateral; angioplasty/stenting if severe; avoid ACEi if bilateral RAS (risk of renal failure)

Interpretation: Hemizygous deletion at 7q11.23 — confirms Williams syndrome
Next step: Proceed to systematic baseline evaluation (see protocol above)
Genetic counselling: Most cases de novo ^[1]; < 5% recurrence risk for future pregnancies (gonadal mosaicism); if parent affected → 50% risk

Aspect	FISH	CMA
Scope	Tests one specific locus only (targeted)	Screens entire genome for CNVs
Resolution	Can detect the typical ~1.5 Mb WS deletion	Can detect typical AND atypical deletions; provides precise breakpoint data
Turnaround	Faster (2–5 days)	Longer (1–3 weeks)
Cost	Lower	Higher
When to use	High clinical suspicion for a specific syndrome (e.g., classic WS facies)	When the diagnosis is uncertain (child with DD + dysmorphism but syndrome not clinically obvious); first-tier test per ACMG guidelines
Additional information	None — binary yes/no for the target region	May reveal other CNVs (incidental findings, VUS); can detect regions of homozygosity (suggesting consanguinity or UPD)

Current Best Practice — First-Line Genetic Test for DD + Dysmorphism

Per ACMG/AAP guidelines (updated through 2025):

CMA is the recommended first-tier test for any child with unexplained developmental delay, intellectual disability, autism spectrum disorder, or multiple congenital anomalies
If CMA is ordered and returns a 7q11.23 deletion, this simultaneously confirms Williams syndrome and screens for other CNVs
FISH remains useful as a rapid targeted confirmatory test when clinical suspicion is already high

Active Recall - Diagnosis and Investigations of Williams Syndrome

References

^[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome) ^[2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) ^[3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) ^[5] Lecture slides: GC 151. The malformed child hereditary syndromes and anomalies.pdf (p. 36 — Rare diseases among common diseases)

Management of Williams Syndrome

Williams syndrome is a lifelong, multisystem genetic condition with no cure — the underlying 7q11.23 deletion cannot be corrected. Management is therefore:

Multidisciplinary and anticipatory — coordinated care across multiple specialties, screening for known complications before they cause harm
Family-centred — parents/caregivers are central partners; genetic counselling is essential
Developmentally supportive — early intervention to maximise each child's potential
System-by-system surveillance — because different complications emerge at different ages
Lifelong — Williams syndrome is not just a paediatric condition; transition planning to adult services is essential

Management Philosophy — Why Anticipatory Surveillance Matters

Because we know the complications Williams syndrome causes (SVAS in ~75%, hypercalcaemia in ~15%, hypothyroidism in ~10%, renal artery stenosis, hypertension ^[1]^[2]), we do not wait for symptoms. We screen proactively at defined intervals so that progressive cardiovascular disease, endocrine dysfunction, or renal complications are caught early — before irreversible damage occurs.

3. Cardiovascular Management

Cardiac involvement occurs in ~75% of patients ^[1]^[2]^[3]. Cardiovascular disease is the leading cause of morbidity and mortality in Williams syndrome.

SVAS is the most common cardiovascular finding ^[2].

Severity	Peak Gradient	Management	Rationale
Mild	< 25 mmHg	Conservative: annual echocardiogram, clinical review, 4-limb BP	Most mild SVAS remains stable; no haemodynamic compromise
Moderate	25–50 mmHg	Closer surveillance: 6-monthly echo; consider cardiac catheterisation if progressive	~20% of moderate SVAS progresses to severe; catheterisation provides precise haemodynamic data and coronary anatomy
Severe	> 50 mmHg, or symptomatic (syncope, angina, heart failure), or progressive LVH	Surgical repair	Severe fixed obstruction → LV pressure overload → LVH → risk of myocardial ischaemia, arrhythmia, heart failure, sudden death

Surgical options for SVAS:

Technique	Description	When Used
Patch aortoplasty (single, Y, or extended)	Augmentation of the narrowed sinotubular junction with a patch (autologous pericardium or synthetic material)	Most common approach for discrete SVAS
McGoon repair (3-patch technique)	Three separate patches placed into each sinus of Valsalva to enlarge the entire aortic root	Diffuse SVAS or when all 3 sinuses are involved
Slide aortoplasty (Brom repair)	The ascending aorta is transected above the stenosis, the distal segment is incised longitudinally in 2 or 3 places and slid down over the proximal segment	Provides excellent geometric reconstruction; increasingly favoured
Ross procedure (rare in WS)	Aortic root replacement using pulmonary autograft	Occasionally considered but complicated by the generalised arteriopathy

Anaesthetic Risk in Williams Syndrome

Williams syndrome patients are at increased risk of sudden cardiac death during anaesthesia and sedation — due to:

Coronary artery ostial stenosis → myocardial ischaemia under haemodynamic stress
Biventricular outflow tract obstruction (SVAS + peripheral PS)
Arrhythmias from ventricular hypertrophy

Pre-anaesthetic checklist (mandatory):

Recent echocardiogram (within 6–12 months)
ECG
4-limb blood pressure
Cardiology review
Anaesthetic management by a paediatric cardiac anaesthetist experienced with WS
Avoid hypotension (maintain preload); avoid tachycardia (reduces coronary filling time)
Have resuscitation drugs readily available

Common in infancy ^[2]; the branch pulmonary arteries are narrowed by the same elastin arteriopathy
Natural history: Tends to improve with age as the pulmonary arteries grow — many cases resolve spontaneously by 2–3 years of age
Management:
- Mild/moderate: Observation; serial echocardiography
- Severe or haemodynamically significant: Balloon angioplasty ± stenting via cardiac catheterisation; rarely requires surgical arterioplasty
- Important to distinguish from isolated valvular PS (as seen in Noonan syndrome) — in WS, the stenosis is in the branch pulmonary arteries, not at the valve

Renal artery stenosis can lead to secondary hypertension ^[2]. Hypertension may also result from generalised elastin arteriopathy (systemic arterial stenosis/stiffness) ^[2]^[3].

Step-by-step approach:

Detect: Measure 4-limb BP at every clinical visit using age-, sex-, and height-specific paediatric percentile tables
- Hypertension = systolic and/or diastolic BP ≥ 95th percentile on ≥ 3 occasions
Investigate: If hypertension confirmed →
- Renal Doppler US (screening for renal artery stenosis ^[2])
- If Doppler suggestive → CTA or MRA for confirmation
- Also check RFT, urinalysis, serum calcium (hypercalcaemia itself can cause hypertension)
Treat:

Scenario	First-Line Treatment	Rationale	Cautions
Unilateral renal artery stenosis	ACE inhibitor (e.g., enalapril) or ARB	Reduces RAAS activation caused by renal hypoperfusion	Monitor creatinine and potassium closely after initiation — if creatinine rises > 30% → suspect bilateral RAS or critical unilateral RAS → stop ACEi/ARB
Bilateral renal artery stenosis	Calcium channel blocker (e.g., amlodipine)	ACEi/ARBs are contraindicated in bilateral RAS because they remove the angiotensin II–mediated efferent arteriolar constriction that maintains GFR in the stenosed kidney → acute kidney injury	Consider interventional radiology (balloon angioplasty ± stenting) if severe
Generalised arteriopathic hypertension (no RAS)	Amlodipine or beta-blocker	Arterial stiffness from elastin deficiency → systolic hypertension	Beta-blockers useful if concurrent LVH
Interventional	Balloon angioplasty ± stenting of renal artery	When RAS is severe and/or refractory to medical therapy	Re-stenosis rate is higher in WS due to ongoing arteriopathy

Paediatric antihypertensive dosing:

Drug	Paediatric Dose	Formulation
Enalapril	0.08–0.1 mg/kg/day, max 0.5 mg/kg/day (max 40 mg/day)	Oral tablet; can be crushed or compounded into liquid
Amlodipine	0.05–0.3 mg/kg/day (max 10 mg/day)	Oral tablet; can be dispersed in water
Atenolol	0.5–1 mg/kg/day (max 2 mg/kg/day)	Oral tablet; liquid formulation available

Current AHA/ESC guidelines (2024–2026): Antibiotic prophylaxis is no longer routinely recommended for most congenital heart lesions, including SVAS, unless:
- Prosthetic valve material has been used (e.g., after surgical repair with synthetic patch)
- History of previous infective endocarditis
- Unrepaired cyanotic CHD (not typical for WS)
Good dental hygiene is emphasised as the primary preventive measure

4. Endocrine and Metabolic Management

Hypercalcaemia (~15%); hypercalciuria (~30%) ^[1]^[2]. Associated with vomiting, feeding difficulties, constipation and prolonged colic ^[2].

Age Group	Management	Details
Neonate/infant with symptomatic hypercalcaemia	Dietary: Use low-calcium infant formula (e.g., Calcilo XD by Abbott) — this formula has minimal calcium and no vitamin D; Avoid excessive vitamin D supplementation	Why low-calcium formula? — The hypercalcaemia in WS is thought to involve increased intestinal calcium absorption. Reducing dietary calcium intake lowers the substrate available for absorption
	Hydration: Ensure adequate fluid intake → promotes renal calcium excretion	Dehydration concentrates calcium; adequate hydration maintains calciuresis
	Avoid vitamin D supplementation until calcium normalises	Standard neonatal vitamin D supplementation (400 IU/day) may worsen hypercalcaemia in WS
	Severe/symptomatic (Ca²⁺ > 3.5 mmol/L or symptomatic with vomiting, lethargy, seizures): IV normal saline hydration + furosemide (loop diuretic)	Normal saline expands intravascular volume → increases renal Ca²⁺ excretion; furosemide inhibits Ca²⁺ reabsorption in the thick ascending limb of the loop of Henle (NKCC2 cotransporter)
	Refractory: Corticosteroids (prednisolone 1–2 mg/kg/day), calcitonin, or bisphosphonates (pamidronate — used with caution in paediatrics)	Corticosteroids reduce intestinal calcium absorption and increase renal excretion; calcitonin inhibits osteoclast activity; bisphosphonates inhibit bone resorption
Infant > 12 months / child	Usually resolves spontaneously by 12 months ^[1]	Continue monitoring; resume normal calcium intake once serum Ca normalises
Ongoing surveillance	Annual serum Ca²⁺ (total + ionised) and urine Ca:Cr ratio, even when normalised	Hypercalcaemia can recur at any age (though rare); hypercalciuria may persist → risk of nephrocalcinosis

Vitamin D Dilemma in Williams Syndrome

A common clinical challenge: all infants in Hong Kong (and most countries) receive routine vitamin D supplementation (400 IU/day) for rickets prevention. But in WS infants with hypercalcaemia, this may worsen the problem.

Rule: In WS infants with documented hypercalcaemia → withhold vitamin D supplementation until serum calcium normalises
Once calcium normalises (usually by ~12 months), standard vitamin D supplementation can be cautiously resumed with monitoring
Children with WS who are normocalcaemic can receive standard vitamin D doses

Hypothyroidism (~10%) ^[1]^[2].

Scenario	Management
Overt hypothyroidism (elevated TSH + low fT4)	Levothyroxine replacement at standard paediatric dosing
Subclinical hypothyroidism (elevated TSH, normal fT4)	Monitor; treat if TSH persistently > 10 mIU/L or symptoms develop
Surveillance	Annual TSH + fT4 from diagnosis, lifelong

Levothyroxine paediatric dosing:

Age	Dose
Neonates (0–3 months)	10–15 mcg/kg/day
Infants (3–12 months)	6–8 mcg/kg/day
Children (1–5 years)	5–6 mcg/kg/day
Children (6–12 years)	4–5 mcg/kg/day
Adolescents	2–3 mcg/kg/day

Formulation: Oral tablet (can be crushed and given with small amount of water); oral liquid available in some regions
Monitor TSH + fT4 every 6–8 weeks after dose changes; annually once stable

Impaired glucose tolerance and overt diabetes mellitus become more common in adolescents and adults with WS
Surveillance: Fasting glucose or HbA1c from adolescence, repeated every 1–2 years
Management: Standard diabetes management if diagnosed (lifestyle modification → metformin → insulin as needed)

Early puberty ^[1] may occur
If precocious puberty is confirmed (onset before age 8 in girls or 9 in boys):
- Investigate as per standard protocol (bone age, LH, FSH, oestradiol/testosterone, pelvic/testicular US, brain MRI to exclude central cause)
- Treat with GnRH agonist (e.g., leuprorelin) if central precocious puberty confirmed — to slow skeletal maturation and preserve final adult height

Issue	Management	Rationale
Failure to thrive (infancy) ^[2]	Optimise caloric intake; occupational therapy for oral motor dysfunction; treat GOR if present; manage hypercalcaemia (which causes vomiting/feeding refusal)	Feeding difficulties are multifactorial: hypotonia → poor suck/swallow coordination; hypercalcaemia → vomiting/anorexia; GOR is common
Short stature ^[1]^[2]	Plot on Williams syndrome-specific growth charts (Morris et al.); exclude hypothyroidism and other treatable causes; ensure adequate nutrition	Using standard growth charts will show consistently low centiles and may trigger unnecessary growth investigations; WS-specific charts provide appropriate reference ranges
Growth hormone	Not routinely recommended — GH is sometimes considered in WS children with documented GH deficiency, but data on efficacy and safety are limited	Concern about potential acceleration of cardiovascular disease (arterial wall changes) with GH therapy in WS
Dietary considerations	Age-appropriate balanced diet; low calcium diet only if hypercalcaemic — do NOT restrict calcium in normocalcaemic WS children	Unnecessary calcium restriction can cause rickets or osteoporosis

6. Developmental and Behavioural Management

This is often the area that has the greatest impact on quality of life for the child and family.

Domain	Intervention	Why
Gross motor	Physiotherapy from infancy	Hypotonia delays motor milestones; physiotherapy builds strength, balance, and coordination
Fine motor / visuospatial	Occupational therapy (OT)	Extreme visuospatial construction deficit ^[2] → OT uses compensatory strategies; teach through verbal-auditory strengths rather than visual-spatial tasks
Language / speech	Speech and language therapy	Although language is relatively preserved, articulation, pragmatics, and comprehension still benefit from therapy; hoarse voice ^[2] may need voice therapy
Feeding	Feeding therapy (OT or SLT)	Oral motor dysfunction in infancy; tongue thrusting, poor chewing

Strategy	Detail
Special educational needs (SEN) assessment	Most children require SEN placement or support within mainstream education
Verbal-auditory learning strategies	Because visuospatial skills are severely impaired but verbal skills are relatively preserved, teaching should leverage auditory and verbal channels (stories, songs, verbal instructions) rather than diagrams, maps, or spatial tasks
Individualised education programme (IEP)	Tailored academic goals; additional classroom support

Issue	Management
Overfriendliness / social vulnerability ^[1]^[2]	Social skills training — teach appropriate social boundaries; stranger awareness programmes; safeguarding measures (the overfriendly nature puts children at risk of exploitation)
Anxiety and specific phobias ^[2]	Cognitive behavioural therapy (CBT) adapted for cognitive level; desensitisation for phobias (especially noise phobia/hyperacusis); anxiolytic medication (SSRIs) only if severe and refractory
ADHD ^[2]	Standard ADHD management: behavioural strategies first-line; methylphenidate if medication needed (start low, titrate slowly; monitor cardiovascular status carefully given underlying cardiac disease)
Sleeping difficulties ^[2]	Sleep hygiene measures; melatonin (0.5–5 mg at bedtime) — commonly used and generally safe in paediatrics for circadian rhythm disturbance

ADHD Medication + Cardiac Disease — A Careful Balance

Stimulant medications (methylphenidate, dexamfetamine) can increase heart rate and blood pressure. In Williams syndrome patients with:

SVAS → increased afterload risk
Coronary ostial stenosis → ischaemic risk with tachycardia
Pre-existing hypertension → may worsen

Rule: Before starting stimulant medication in a WS child, obtain a recent echocardiogram, ECG, and BP measurement. Monitor cardiovascular parameters regularly. Use the lowest effective dose. Non-stimulant alternatives (atomoxetine, guanfacine) may be preferred if cardiac concerns are significant.

Issue	Management	Rationale
Renal artery stenosis ^[2]^[3]	Antihypertensives ± angioplasty (see Section 3.3)	Elastin arteriopathy
CAKUT ^[2]	Manage per specific anomaly (e.g., VUR prophylaxis, monitoring for UTIs)	Structural anomalies may predispose to infection or obstruction
Nephrocalcinosis	Ensure adequate hydration; treat hypercalciuria; avoid excessive calcium/vitamin D	Chronic hypercalciuria → calcium deposition in renal parenchyma → progressive renal damage
Bladder dysfunction	Urotherapy; timed voiding; anticholinergics if overactive bladder	Enuresis and daytime incontinence are common; connective tissue laxity may contribute to bladder dysfunction

Issue	Management
Chronic otitis media ^[1]	Standard management: watchful waiting → antibiotics for acute OM → grommet insertion if recurrent/chronic OME with hearing loss
Sensorineural hearing loss (high-frequency) ^[2]	Hearing aids if moderate-severe; regular audiological follow-up
Hyperacusis ^[1]	Desensitisation therapy (gradual exposure to tolerable sound levels); noise-dampening earplugs/headphones for distressing situations; reassurance and education

Issue	Management
Strabismus ^[2]	Orthoptic assessment; patching; surgical correction if significant
Refractive errors	Corrective lenses
Hypertensive retinopathy	Treat hypertension; fundoscopic monitoring

Dental problems including microdontia, enamel hypoplasia, malocclusion, excessive interdental spacing ^[2].

Issue	Management
Enamel hypoplasia	Fluoride varnish; sealants; careful dental hygiene education
Malocclusion	Orthodontic referral
Dental caries risk	Regular dental review (every 6 months); fluoride supplementation where appropriate
Anaesthetic considerations	Dental procedures requiring sedation/GA must follow the WS anaesthetic precautions (see Section 3.1)

Issue	Management
Kyphoscoliosis ^[1]	Physiotherapy; orthopaedic monitoring; bracing if progressive; surgical correction rarely needed
Joint hypermobility (childhood)	Physiotherapy for joint stability; supportive footwear
Joint contractures (adolescence/adulthood)	Stretching; physiotherapy; OT for adaptive devices

Scenario	Counselling
De novo deletion (majority) ^[1]	Parents are NOT carriers; recurrence risk is < 5% (accounting for possible gonadal mosaicism). Reassurance that this was a random event during meiosis
Affected parent	50% risk to each offspring (autosomal dominant). Offer prenatal diagnosis (chorionic villus sampling at 11–13 weeks or amniocentesis at 15–18 weeks with FISH/CMA for 7q11.23)
Affected individual reaching reproductive age	Discuss 50% transmission risk; offer preimplantation genetic testing (PGT) if IVF considered; non-directive counselling

Williams syndrome is a lifelong condition. Paediatric services must plan transition to adult care:

Aspect	Details
Timing	Begin transition planning at 14–16 years; complete by 18–25 years
Adult medical care	Ongoing cardiology surveillance (SVAS can progress into adulthood); endocrine monitoring; BP monitoring; metabolic screening
Psychosocial	Supported living arrangements (most adults with WS require some level of support); vocational training; social skills support; legal capacity assessment
Mental health	Anxiety disorders are common in adults with WS; ongoing psychiatric/psychological support
Life expectancy	Shorter life expectancy ~60 years ^[6] — primarily due to cardiovascular complications

Age	Key Actions
Diagnosis	Baseline echo, ECG, 4-limb BP; serum Ca²⁺ + urine Ca:Cr; TSH/fT4; renal US + Doppler; RFT/urinalysis; audiology; ophthalmology; developmental assessment; dental assessment; genetic counselling
0–12 months	6-monthly echo (if cardiac lesion); serial calcium monitoring; feeding support; early intervention enrolment
1–5 years	Annual echo (or more frequent if moderate-severe lesion); annual TSH, calcium, BP; developmental review; audiology; ophthalmology
5–12 years	Annual echo, BP, TSH, calcium; educational support review; behavioural assessment (ADHD, anxiety); scoliosis screening
12–18 years	Annual echo, BP, TSH, calcium; fasting glucose/HbA1c (start in adolescence); pubertal assessment; transition planning
> 18 years	Lifelong cardiology, endocrine, renal surveillance; mental health support; vocational support

Incorrect Action	Why It Is Wrong
Restricting calcium in all WS patients	Only restrict calcium if hypercalcaemic; normocalcaemic patients need normal calcium intake for bone health
Giving standard vitamin D doses to a hypercalcaemic WS infant	May worsen hypercalcaemia — withhold until calcium normalises
Ignoring cardiovascular assessment before any sedation	Risk of sudden cardiac death — always obtain pre-anaesthetic cardiac review
Using standard growth charts as the sole reference	WS children will always track low; use WS-specific growth charts to avoid unnecessary investigation for "failure to thrive"
Treating ADHD with stimulants without cardiac evaluation	Risk of cardiovascular complications in a child with SVAS and/or coronary disease

High Yield Summary — Management of Williams Syndrome

No cure — management is multidisciplinary, anticipatory, and lifelong
Cardiovascular (greatest source of morbidity/mortality):
- SVAS: Mild → observe; moderate → close surveillance; severe → surgical repair (patch aortoplasty, slide aortoplasty)
- Peripheral PS: Often improves with age; balloon angioplasty if severe
- Hypertension: Investigate for renal artery stenosis ^[2]; treat with ACEi (if unilateral RAS) or CCB (if bilateral); angioplasty if refractory
- Pre-anaesthetic cardiac review mandatory — risk of sudden cardiac death
Endocrine:
- Hypercalcaemia: Low-calcium formula in infancy; avoid vitamin D if hypercalcaemic; IV NS + furosemide if severe; usually resolves by 12 months ^[1]
- Hypothyroidism: Levothyroxine replacement; annual screening
Development: Early intervention (physio, OT, SLT); leverage verbal-auditory strengths; SEN support
Behaviour: Social skills training for overfriendliness/safeguarding; CBT/SSRIs for anxiety; melatonin for sleep; methylphenidate for ADHD (with cardiac precautions)
Growth: WS-specific growth charts; optimise nutrition; GH not routinely recommended
Renal: Monitor for RAS, CAKUT, nephrocalcinosis
Genetic counselling: De novo ~95%, < 5% recurrence; 50% if parent affected
Shorter life expectancy ~60 years ^[6] — cardiovascular disease is the main determinant

Active Recall - Management of Williams Syndrome

References

^[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome) ^[2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) ^[3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) ^[6] Senior notes: Maksim Paediatric Notes.pdf (p. 206 — Williams syndrome)

Complications of Williams Syndrome

Complications in Williams syndrome arise from two fundamental mechanisms:

Elastin arteriopathy — the haploinsufficiency of the ELN gene produces a generalised vasculopathy affecting any artery ^[2]^[3]. This single mechanism drives the majority of the serious, life-threatening complications.
Contiguous gene effects — the ~26–28 other deleted genes produce neurocognitive, endocrine, connective tissue, and growth-related complications that accumulate over a lifetime.

Because Williams syndrome is lifelong, complications evolve with age — some are prominent in infancy (hypercalcaemia, feeding difficulties, peripheral PS), others emerge later (hypertension, diabetes, progressive SVAS, anxiety disorders). Understanding this temporal pattern is essential for anticipatory surveillance.

2. Cardiovascular Complications

Cardiovascular disease is the leading cause of morbidity and mortality and the principal determinant of shorter life expectancy (~60 years) ^[6].

Supravalvular AS is the most common cardiovascular finding ^[2]
Why it progresses: With ongoing growth, the aortic wall at the sinotubular junction continues to thicken due to smooth muscle hyperplasia and collagen deposition compensating for elastin deficiency. The stenosis does not self-correct — unlike peripheral PS, which may improve as pulmonary arteries grow.
Consequences of progressive SVAS:

Consequence	Mechanism
Left ventricular hypertrophy (LVH)	Chronic pressure overload → concentric LVH (wall thickens to generate more force against increased afterload)
Left ventricular failure	Prolonged LVH eventually leads to diastolic dysfunction (stiff, non-compliant ventricle) and ultimately systolic failure
Aortic regurgitation	Structural distortion of the aortic root from the stenotic segment can affect valve coaptation
Post-stenotic aortic dilation	Turbulent jet beyond the stenosis → localised aortic wall stress and dilation (less common in WS than in valvular AS because the arterial wall is stiff from elastin deficiency)

Coronary artery ostial stenosis ^[3] — this is the most feared cardiovascular complication.

Why does this happen?

The coronary arteries originate from the aortic sinuses of Valsalva, which are below the supravalvular stenosis
The coronary ostia are embedded within the thickened, elastin-deficient aortic wall
As the sinotubular junction narrows, the coronary ostia become progressively encroached upon
Additionally, the coronary arteries are exposed to high LV systolic pressure (because they arise proximal to the obstruction), causing:
- Coronary artery dilation and tortuosity
- Accelerated atherosclerosis
- Intimal thickening at the ostia

Complication	Clinical Manifestation	Risk Setting
Myocardial ischaemia	Chest pain, ST-T changes on ECG, troponin elevation	Exercise, stress, anaesthesia
Myocardial infarction	Acute chest pain, haemodynamic collapse	Can occur even in childhood
Sudden cardiac death	Cardiac arrest, ventricular fibrillation	Especially during anaesthesia/sedation — the combination of reduced afterload (anaesthetic agents) + fixed coronary obstruction + tachycardia (reduced diastolic filling time) is lethal

Sudden Cardiac Death — The Most Critical Complication

The risk of sudden cardiac death in Williams syndrome is estimated at approximately 1 in 1,000 per year — significantly higher than the general paediatric population. The risk is highest in patients with:

Severe biventricular outflow tract obstruction (SVAS + peripheral PS)
Coronary artery ostial stenosis
During anaesthesia or sedation — multiple case reports document cardiac arrest during routine dental or diagnostic procedures

This is why every anaesthetic encounter must include pre-procedure cardiac evaluation (echocardiogram, ECG, cardiology review) and be performed by an experienced paediatric cardiac anaesthetist ^[3].

Stenosis of arterial system — systemic arterial stenosis, renal artery stenosis ^[3].

The generalised elastin arteriopathy means that any medium or large artery in the body can develop stenosis. This produces a range of secondary complications:

Artery Affected	Complication	Mechanism	Clinical Consequence
Renal arteries ^[2]^[3]	Secondary hypertension	Renal artery stenosis → reduced renal perfusion → RAAS activation → ↑ angiotensin II → vasoconstriction + aldosterone secretion → salt/water retention + ↑ SVR	Systemic hypertension; if untreated → LVH (on top of SVAS-induced LVH), hypertensive nephropathy, hypertensive retinopathy, stroke
Mesenteric arteries	Mesenteric ischaemia	Narrowing of coeliac/SMA/IMA → reduced gut perfusion	Postprandial abdominal pain ("intestinal angina"); rarely, bowel infarction
Cerebral arteries	Cerebrovascular stenosis	Intracranial arterial narrowing → reduced cerebral perfusion	Stroke (rare in children, more common in adults); moyamoya-like disease has been described
Aorta (beyond sinotubular junction)	Coarctation-like narrowing	Elastin deficiency in mid-aortic segment	"Middle aortic syndrome" → upper/lower limb BP gradient; severe hypertension
Peripheral arteries	Claudication, limb ischaemia	Stenosis of iliac, femoral, or other limb arteries	Rare in childhood; may manifest in adulthood

Hypertension prevalence: Up to 50–60% of adolescents and adults with WS have hypertension — this is far higher than the ~15% figure for hypercalcaemia, making hypertension one of the most common ongoing complications to monitor.

Peripheral pulmonary stenosis common in infancy ^[2].

In most cases, PPS improves with age as the pulmonary arteries grow relative to body size
Complications of severe PPS:
- Right ventricular pressure overload → RVH → right heart failure
- Unequal pulmonary blood flow → ventilation-perfusion mismatch → hypoxaemia
- Combined with SVAS → biventricular outflow tract obstruction → highest risk of haemodynamic collapse

Arise secondary to:
- Ventricular hypertrophy (LVH from SVAS, RVH from PPS) → altered conduction substrate → re-entry circuits
- Myocardial fibrosis from chronic pressure overload
- Coronary ischaemia → ischaemic arrhythmias
Can manifest as ventricular tachycardia, ventricular fibrillation, or sudden cardiac death

3. Endocrine and Metabolic Complications

Hypercalcaemia (~15%) and hypercalciuria (~30%) ^[1]^[2]. Associated with vomiting, feeding difficulties, constipation and prolonged colic ^[2].

Complication	Mechanism	Age
Feeding difficulties / failure to thrive	Hypercalcaemia → anorexia, nausea, vomiting; also decreases GI motility → constipation	Infancy
Nephrocalcinosis	Chronic hypercalciuria → calcium salt precipitation in renal parenchyma	Any age (even after serum Ca normalises, if hypercalciuria persists)
Renal stones (nephrolithiasis)	Same mechanism — supersaturation of calcium in urine	Childhood–adulthood
Nephrogenic diabetes insipidus	Ca²⁺ interferes with aquaporin-2 (AQP2) expression in the collecting duct → impaired water reabsorption → polyuria, polydipsia	If hypercalcaemia is severe or prolonged
Constipation	Hypercalcaemia → decreased smooth muscle contractility in the GI tract → reduced peristalsis	Infancy
Cardiac effects	Hypercalcaemia → shortened QT interval on ECG → at extreme levels, risk of cardiac arrest	Neonatal (if very severe)

Important nuance: Even when serum calcium normalises (usually by 12 months ^[1]), hypercalciuria may persist in ~30% ^[2]. This silent hypercalciuria drives ongoing renal complications (nephrocalcinosis, stones) even when clinicians believe the calcium problem has "resolved." This is why urine Ca:Cr monitoring must continue beyond infancy.

Hypothyroidism (~10%) ^[1]^[2].

May present as subclinical (elevated TSH, normal fT4) or overt (elevated TSH, low fT4)
Consequences if untreated:
- In young children: Worsens developmental delay, lethargy, constipation, weight gain, growth deceleration — all of which may be mistakenly attributed to WS itself rather than treatable hypothyroidism
- In adolescents/adults: Fatigue, depression, dyslipidaemia, weight gain
Key point: Because many symptoms of hypothyroidism overlap with WS features (short stature, developmental delay, constipation), hypothyroidism may be missed unless systematically screened with annual TSH + fT4

Prevalence increases with age — up to 35–40% of adults with WS have impaired glucose tolerance, and ~15% develop overt type 2 diabetes mellitus
Mechanism: Likely related to STX1A deletion (syntaxin 1A — involved in insulin vesicle exocytosis from beta cells) + obesity risk + reduced physical activity
Complications: Standard diabetic complications (retinopathy, nephropathy, neuropathy, cardiovascular disease) — compounded by the pre-existing arteriopathy

Early puberty ^[1].

Central precocious puberty → if untreated:
- Accelerated skeletal maturation → premature epiphyseal fusion → compromised final adult height (already reduced in WS)
- Psychosocial consequences of early pubertal development in a child with intellectual disability

4. Neurocognitive and Behavioural Complications

Developmental delay and intellectual disability (~75%): usually mild-moderate ^[1].

Extreme deficits in visuospatial construction ^[2] → difficulty with mathematics, science, map reading, handwriting, design tasks
The verbal-performance IQ discrepancy can mislead teachers and parents into overestimating the child's overall ability based on their verbal fluency

Complication	Prevalence	Mechanism	Clinical Significance
Anxiety disorders ^[2]	~50–60% of children and adults	Generalised anxiety, specific phobias (especially noise phobia related to hyperacusis ^[1]), social anxiety (paradoxically, despite overfriendliness)	Can be severely debilitating; often the most distressing problem for families
Depression	Common in adolescents/adults	Increasing awareness of social difficulties + limited independence + social isolation	May be underdiagnosed due to communication limitations
ADHD ^[2]	~60–80%	Executive function deficits	Affects learning, behaviour management, and safety
Sleeping difficulties ^[2]	Very common	Anxiety + possible melatonin dysregulation	Disrupts family function; worsens daytime behaviour
Obsessive-compulsive features	Some patients	Related to anxiety spectrum	Repetitive questioning, routines

Overfriendliness / "cocktail party" personality ^[1]^[2].

The hallmark behavioural feature of WS is the indiscriminate approach to strangers — intense eye contact, verbal engagement, physical proximity
Why is this a complication? Because it creates:
- Safeguarding risk — children and adolescents with WS are vulnerable to exploitation, abuse, and manipulation by strangers
- Difficulty forming deep friendships — the social approach is superficial; children with WS struggle with reciprocity, turn-taking, and reading social cues
- Social isolation in adulthood — peers find the overfriendliness inappropriate; individuals with WS often have few genuine friendships

Complication	Mechanism	Consequence
Renal artery stenosis ^[2]^[3]	Elastin arteriopathy → narrowing of renal artery	Secondary hypertension → LVH, hypertensive nephropathy, stroke risk
Nephrocalcinosis	Chronic hypercalciuria → calcium deposition in renal parenchyma	Progressive renal impairment; may cause recurrent UTIs
Nephrolithiasis	Calcium supersaturation in urine	Renal colic; obstruction; infection
CAKUT ^[2]	Congenital anomalies (horseshoe kidney, VUR, duplex, agenesis)	Recurrent UTIs; CKD if severe
Bladder dysfunction	Connective tissue laxity + possible neurogenic component	Enuresis; urinary incontinence; recurrent UTIs
Chronic kidney disease	Cumulative effect of RAS + nephrocalcinosis + CAKUT + hypertensive nephropathy	Progressive renal failure; may require dialysis in severe cases (rare)

Complication	Mechanism	Age
Failure to thrive ^[2]	Feeding difficulties (oral motor dysfunction, hypotonia, GOR) + hypercalcaemia (vomiting, anorexia) + caloric insufficiency	Infancy
Short stature ^[1]^[2]	Intrinsic growth pattern of WS + possible endocrine factors (hypothyroidism, early puberty → premature fusion) + nutritional insufficiency in infancy	Lifelong
Obesity	Reduced physical activity (hypotonia, joint problems, cognitive limitations) + food as comfort/social behaviour	School age–adulthood
Gastro-oesophageal reflux	Lower oesophageal sphincter hypotonia (connective tissue laxity); feeding difficulties	Infancy–early childhood
Chronic constipation	Smooth muscle hypotonia (connective tissue component) + hypercalcaemia + dietary factors	Any age

Hearing impairment: chronic otitis media, hyperacusis ^[1]. Sensorineural (high-tone) or conductive hearing loss ^[2].

Complication	Mechanism	Consequence
Chronic/recurrent otitis media	Eustachian tube dysfunction (possibly related to craniofacial anatomy)	Conductive hearing loss; language delay; recurrent infections requiring antibiotics or grommets
Progressive sensorineural hearing loss	Cochlear changes (mechanism not fully understood — possibly related to connective tissue changes in the organ of Corti)	Insidious high-frequency hearing loss → difficulty hearing consonants → impacts speech comprehension
Hyperacusis ^[1]	Altered central auditory processing → heightened sensitivity to ordinary environmental sounds	Distress, avoidance behaviours, noise phobia → can be severely limiting (child refuses to attend noisy environments → school assemblies, birthday parties)

Complication	Mechanism	Age Pattern
Kyphoscoliosis ^[1]	Connective tissue laxity from elastin deficiency → poor spinal ligament support	Childhood; may progress in adolescence
Joint hypermobility → contractures	Childhood: laxity from elastin deficiency; Adulthood: compensatory muscle tightening → progressive joint contractures	Hypermobility in childhood transitions to contractures in adolescence/adulthood (a classic pattern in WS)
Inguinal and umbilical hernias	Connective tissue weakness in the abdominal wall	Infancy–childhood
Rectal prolapse	Connective tissue laxity of pelvic floor	Rare; childhood
Pes planus (flat feet)	Ligamentous laxity	Childhood

Dental problems including microdontia, enamel hypoplasia, malocclusion, excessive interdental spacing ^[2].

Enamel hypoplasia → increased caries susceptibility
Malocclusion → difficulty chewing; cosmetic concerns
Small teeth with wide spacing → cosmetic and functional impact
Dental procedures carry increased risk due to the need for sedation/GA and the associated cardiac risks (see cardiovascular complications)

Complication	Detail
Strabismus ^[2]	May cause amblyopia if not corrected early → permanent visual loss in the deviated eye
Hypermetropia	Common refractive error; corrected with glasses
Hypertensive retinopathy	Secondary to systemic hypertension — fundoscopic changes (arteriolar narrowing, AV nipping, haemorrhages, papilloedema in severe cases)

Age	Key Complications to Watch For
Neonate	Hypercalcaemia, feeding difficulties, cardiac murmur (PPS > SVAS at this age), prolonged jaundice
Infant (1–12 months)	Failure to thrive, GOR, constipation, persistent hypercalcaemia, PPS haemodynamic significance
Toddler (1–3 years)	SVAS progression, developmental delay becoming apparent, hypercalcaemia usually resolving
Preschool (3–5 years)	Visuospatial deficits identified; behavioural problems (overfriendliness, anxiety, ADHD); scoliosis screening
School age (5–12 years)	Academic difficulties; behavioural/mental health (anxiety, phobias, ADHD); hypertension emerging; progressive SVAS; hypothyroidism
Adolescence (12–18 years)	Hypertension (up to 50%); glucose intolerance; early puberty; obesity; mental health (depression, anxiety); joint contractures replacing hypermobility; transition planning
Adulthood (> 18 years)	Progressive SVAS; coronary disease; hypertension; DM; CKD; hearing loss; depression/anxiety; social isolation; reduced life expectancy

Shorter life expectancy ~60 years ^[6].

Factor	Impact on Prognosis
Severity of SVAS	The most important single prognostic factor; severe SVAS requiring surgery or causing LV failure shortens life significantly
Coronary artery disease	Sudden cardiac death risk; myocardial infarction
Hypertension	Accelerates end-organ damage (cardiac, renal, cerebrovascular)
Renal disease	CKD from combined RAS + nephrocalcinosis + hypertensive nephropathy
Quality of multidisciplinary care	Early and consistent surveillance with proactive management of complications substantially improves outcomes

High Yield Summary — Complications of Williams Syndrome

Cardiovascular (greatest source of mortality):

Progressive SVAS → LVH → heart failure ^[2]^[3]
Coronary artery ostial stenosis → myocardial ischaemia → sudden cardiac death (especially under anaesthesia) ^[3]
Renal artery stenosis → secondary hypertension ^[2]^[3]
Systemic arterial stenosis (any artery) → mesenteric ischaemia, cerebrovascular stenosis, middle aortic syndrome ^[3]
Peripheral PS → usually improves; severe cases → RV failure ^[2]

Endocrine/Metabolic:

Hypercalcaemia → feeding difficulties, constipation, nephrocalcinosis, nephrolithiasis ^[1]^[2]
Hypothyroidism → worsens developmental delay if undetected ^[1]^[2]
Impaired glucose tolerance / DM (adolescence/adulthood)
Early puberty → compromised final height ^[1]

Neurocognitive/Behavioural:

Intellectual disability (mild-moderate, ~75%) with extreme visuospatial deficit ^[1]^[2]
Anxiety disorders, phobias (noise), depression, ADHD ^[2]
Social vulnerability from overfriendliness ^[1]^[2]

Renal: Nephrocalcinosis, nephrolithiasis, CAKUT, CKD ^[2] Hearing: Progressive SNHL, chronic OM, hyperacusis ^[1]^[2] MSK: Kyphoscoliosis, joint contractures ^[1] Growth: FTT, short stature, obesity ^[1]^[2] Life expectancy: ~60 years ^[6]

Active Recall - Complications of Williams Syndrome

References

^[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome) ^[2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) ^[3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) ^[5] Lecture slides: GC 151. The malformed child hereditary syndromes and anomalies.pdf (p. 36 — Rare diseases among common diseases) ^[6] Senior notes: Maksim Paediatric Notes.pdf (p. 206 — Williams syndrome)

High Yield Summary

Williams Syndrome — Key Facts for Exams:

7q11.23 microdeletion including the elastin (ELN) gene — majority de novo ^[1]^[2]
Elfin facies: broad forehead, periorbital fullness, flat nasal bridge, anteverted nares, long philtrum, full lips, wide mouth, small widely spaced teeth, prominent ears, stellate iris ^[1]^[2]
Supravalvular aortic stenosis — most common and most characteristic cardiac lesion ^[2]^[3]
Peripheral pulmonary stenosis — common in infancy, often improves ^[2]
Elastin arteriopathy → any artery can be affected → renal artery stenosis → hypertension ^[2]^[3]
Coronary ostial stenosis → risk of sudden cardiac death (especially under anaesthesia)
Intellectual disability (75%, mild-moderate) with characteristic profile: preserved language, extreme visuospatial deficit ^[1]^[2]
Overfriendly / "cocktail party" personality — pathognomonic behavioural phenotype ^[1]^[2]
Hypercalcaemia (~15%) — transient neonatal, causes feeding difficulties and colic; hypercalciuria (~30%) ^[1]^[2]
Hypothyroidism (~10%) ^[1]^[2]; early puberty ^[1]
Short stature / failure to thrive ^[1]^[2]
Hyperacusis and sensorineural/conductive hearing loss ^[1]^[2]
Diagnosis by FISH or chromosomal microarray (CMA) — not visible on standard karyotype
Associations to remember: WILLIAMS = Wide mouth, Increased Ca²⁺, Long philtrum, Learning difficulties, Iris (stellate), Aortic stenosis (supravalvular), Mental retardation, Small stature/teeth

High Yield Summary — Differential Diagnosis of Williams Syndrome

When to suspect Williams syndrome over mimics:

Supravalvular AS is virtually pathognomonic — no other common syndrome produces it ^[2]^[3]
Elfin facies + hypercalcaemia + overfriendliness = Williams until proven otherwise ^[1]^[2]
Calcium direction distinguishes WS (↑Ca²⁺) from DiGeorge (↓Ca²⁺)
Cardiac lesion type distinguishes all major syndromes: SVAS = Williams, AVSD = Down, valvular PS = Noonan, coarctation = Turner, conotruncal = DiGeorge ^[1]^[3]^[5]^[6]
The GC lecture groups Williams with 22q11.2 deletion, Marfan, Noonan, Loeys-Dietz, and Long QT as "rare diseases among common diseases" ^[5] — know all their cardiac associations
Familial isolated SVAS (ELN point mutations) is the closest genetic differential — same cardiac lesion but no dysmorphism, cognitive, or behavioural features

High Yield Summary — Management of Williams Syndrome

No cure — management is multidisciplinary, anticipatory, and lifelong
Cardiovascular (greatest source of morbidity/mortality):
- SVAS: Mild → observe; moderate → close surveillance; severe → surgical repair (patch aortoplasty, slide aortoplasty)
- Peripheral PS: Often improves with age; balloon angioplasty if severe
- Hypertension: Investigate for renal artery stenosis ^[2]; treat with ACEi (if unilateral RAS) or CCB (if bilateral); angioplasty if refractory
- Pre-anaesthetic cardiac review mandatory — risk of sudden cardiac death
Endocrine:
- Hypercalcaemia: Low-calcium formula in infancy; avoid vitamin D if hypercalcaemic; IV NS + furosemide if severe; usually resolves by 12 months ^[1]
- Hypothyroidism: Levothyroxine replacement; annual screening
Development: Early intervention (physio, OT, SLT); leverage verbal-auditory strengths; SEN support
Behaviour: Social skills training for overfriendliness/safeguarding; CBT/SSRIs for anxiety; melatonin for sleep; methylphenidate for ADHD (with cardiac precautions)
Growth: WS-specific growth charts; optimise nutrition; GH not routinely recommended
Renal: Monitor for RAS, CAKUT, nephrocalcinosis
Genetic counselling: De novo ~95%, < 5% recurrence; 50% if parent affected
Shorter life expectancy ~60 years ^[6] — cardiovascular disease is the main determinant

High Yield Summary — Complications of Williams Syndrome

Cardiovascular (greatest source of mortality):

Progressive SVAS → LVH → heart failure ^[2]^[3]
Coronary artery ostial stenosis → myocardial ischaemia → sudden cardiac death (especially under anaesthesia) ^[3]
Renal artery stenosis → secondary hypertension ^[2]^[3]
Systemic arterial stenosis (any artery) → mesenteric ischaemia, cerebrovascular stenosis, middle aortic syndrome ^[3]
Peripheral PS → usually improves; severe cases → RV failure ^[2]

Endocrine/Metabolic:

Hypercalcaemia → feeding difficulties, constipation, nephrocalcinosis, nephrolithiasis ^[1]^[2]
Hypothyroidism → worsens developmental delay if undetected ^[1]^[2]
Impaired glucose tolerance / DM (adolescence/adulthood)
Early puberty → compromised final height ^[1]

Neurocognitive/Behavioural:

Intellectual disability (mild-moderate, ~75%) with extreme visuospatial deficit ^[1]^[2]
Anxiety disorders, phobias (noise), depression, ADHD ^[2]
Social vulnerability from overfriendliness ^[1]^[2]

Memory palace for Williams Syndrome

Memory palace hooks for Williams Syndrome

How to Use This Memory Palace

Each numbered symbol is a recall hook mapped back to this page's own notes. The Note concept column is the source of truth; the symbol logic explains why the visual cue should trigger that concept.

This first pass maps the supplied Williams syndrome labels 28-54. Any additional labels visible in the image should be added only after they are tied back to the MBBSPedia note sections.

Feature Guardrail

The supplied Sketchy nose hook is a Williams facial-feature cue, but this page's note wording lists a flat nasal bridge with anteverted nares rather than a DiGeorge-like bulbous nasal tip. Use the Note concept column as the source of truth when recalling facial findings.

No.	Symbol	Source tab	Note concept	Etymology / symbol logic
28	Governor Williams with "7q11.23"	Etiology / Summary	Williams syndrome is caused by a hemizygous microdeletion at 7q11.23, including the elastin gene.	Governor Williams anchors the syndrome name; 7q11.23 is the chromosomal address.
29	Irritable Governor Williams	Etiology	Infants may have irritability, excessive crying, colic, and distress from hypercalcaemia or hyperacusis.	The irritable governor turns early nonspecific crying into a Williams clue.
30	Vomiting figure with raised milk bottle	Etiology / Dx / Mx	Transient neonatal hypercalcaemia can cause vomiting, feeding difficulties, constipation, and prolonged colic.	Milk cues calcium; the raised bottle cues high calcium rather than low calcium.
31	Food falling	Etiology / Mx / Complications	Feeding difficulties and failure to thrive are common in infancy from oral motor dysfunction, hypotonia, GOR, and hypercalcaemia.	Food that cannot be held down cues vomiting, poor intake, and poor weight gain.
32	Baby throwing bottle	Etiology / Mx / Complications	Failure to thrive in infancy reflects feeding difficulty, hypotonia, reflux, and sometimes hypercalcaemia-related anorexia or vomiting.	The baby rejecting the bottle cues feeding refusal and poor growth.
33	Hypotonic kid	Etiology / Dx / Mx	Hypotonia in infancy contributes to motor delay, feeding difficulty, and delayed walking.	The floppy child cues low tone as a developmental and feeding contributor.
34	Figure covering ears	Etiology / Dx / Mx / Complications	Hyperacusis and hearing impairment are common; hyperacusis can drive noise phobia and distress.	Covered ears cue sound sensitivity and audiology follow-up.

No.	Symbol	Source tab	Note concept	Etymology / symbol logic
35	Tray of cocktails	Etiology / Mx / Complications	Williams syndrome has an overfriendly "cocktail party" personality with social vulnerability.	Cocktails cue fluent, indiscriminate social approach.
36	Elf mask	Etiology / Dx / Summary	Characteristic elfin facies include broad forehead, periorbital fullness, flat nasal bridge, long philtrum, full lips, wide mouth, small widely spaced teeth, prominent ears, and small chin.	The elf mask packages the Williams facial gestalt.
37	Elf mask with periorbital fullness	Etiology / Dx	Periorbital fullness is a classic Williams facial feature.	Puffy tissue around the elf eyes cues periorbital fullness.
38	Elf mask with nose cue	Etiology / Dx	This page describes flat nasal bridge with anteverted nares as part of the Williams facial pattern.	The nose on the elf mask cues the Williams nasal configuration, using the page's wording as the source of truth.
39	Elf mask with wide mouth	Etiology / Dx / Summary	Full or thick lips and a wide mouth are part of the characteristic elfin facies.	The wide mouth makes the "W" in the WILLIAMS mnemonic visible.
40	Starry glasses	Etiology / Dx / Summary	Stellate iris pattern is a distinctive Williams sign, seen in about half of patients.	Stars over the eyes cue the star-like iris pattern.
41	Long face	Etiology	Williams facial features become more recognisable with age and may coarsen over time.	The changing face cue reminds you that the gestalt evolves as the child grows.

No.	Symbol	Source tab	Note concept	Etymology / symbol logic
42	Microarray tea chest	Dx / Summary	Williams syndrome is confirmed by FISH, chromosomal microarray, or MLPA showing the 7q11.23 deletion; standard karyotype is normal.	"Tea chest" cues chromosomal microarray as the broad CNV test.
43	Tray of milks	Dx / Mx / Summary	Check serum total and ionised calcium and urine calcium:creatinine ratio because hypercalcaemia and hypercalciuria are common.	Multiple milk bottles cue measuring calcium burden in blood and urine.
44	Williams syndrome DDx sign	DDx	Differential diagnoses include Down, Noonan, Turner, DiGeorge, Marfan, Fragile X, fetal alcohol spectrum disorder, and isolated familial SVAS.	The DDx sign turns Williams into the index syndrome among dysmorphic cardiac mimics.

No.	Symbol	Source tab	Note concept	Etymology / symbol logic
45	Ultrasound megaphone with heart boat whistle	Dx / Mx / Complications	Echocardiography evaluates supravalvular aortic stenosis, peripheral pulmonary stenosis, LVH, and cardiac risk.	The ultrasound cue scans the hallmark Williams heart lesion.
46	Four extremity bracelets	Dx / Mx	Four-limb blood pressure measurement screens for hypertension, BP discrepancy, and arterial stenosis physiology.	Bracelets on all limbs cue BP checks in all four extremities.
47	High-pressure steam	Etiology / Dx / Mx / Complications	Williams syndrome carries high risk of systemic hypertension, often from renal artery stenosis or generalised elastin arteriopathy.	Steam pressure cues vascular pressure from narrowed arteries.
48	Small kidney pulley	Dx / Mx / Complications	Renal ultrasound with Doppler screens for CAKUT, nephrocalcinosis, and renal artery stenosis.	The pulled kidney cues structural and renovascular screening.
49	Telescope	Dx / Mx	Ophthalmology evaluates stellate iris, strabismus, refractive errors, and hypertensive retinopathy risk.	The telescope cue points to formal eye assessment.
50	Undone thyroid bowtie	Dx / Mx / Complications	Check TSH and free T4 because hypothyroidism is common and can worsen growth and developmental problems if missed.	The loose thyroid bowtie cues thyroid-function testing.

No.	Symbol	Source tab	Note concept	Etymology / symbol logic
51	Gnome-like sailor	Etiology / Mx / Summary	Short stature is typical; growth should be plotted on Williams syndrome-specific growth charts.	The small figure cues short stature and syndrome-specific growth expectations.
52	"Expect Delays" buoy	Etiology / Dx / Mx / Complications	Developmental delay and intellectual disability are common, with relatively preserved language but marked visuospatial deficits.	The delay sign cues formal developmental and educational assessment.
53	Rope wrapped around arm and leg	Etiology / Mx / Complications	Joint laxity in childhood can evolve into joint contractures in adolescence or adulthood.	Rope around limbs cues the hypermobility-to-contracture pattern.
54	"Sleep free or die" sign	Etiology / Mx / Complications	Williams syndrome carries increased sudden cardiac death risk during anaesthesia or sedation, so pre-anaesthetic cardiac review is mandatory.	The sleep/anesthesia warning sign cues that sedation is the danger moment.

Williams Syndrome

1. Definition

2. Epidemiology

3. Anatomy and Function of Key Deleted Genes

4. Aetiology and Pathophysiology

4.1 Genetic Aetiology

4.2 Pathophysiology by System

A. Cardiovascular (~75% of patients [1][2][3])

B. Craniofacial — The "Elfin" Facies

C. Neurological / Neurocognitive

D. Behavioural Phenotype

E. Endocrine

F. Growth

G. Renal

H. Musculoskeletal / Connective Tissue

I. Hearing

5. Classification

5.1 By Deletion Size

5.2 By Inheritance Pattern

5.3 Related Conditions on the Same Genetic Spectrum

6. Clinical Features

6.1 Symptoms (What the Family Reports)

6.2 Signs (What the Clinician Finds)

A. General Inspection

B. Cardiovascular Examination

C. Neurological Examination

D. Abdominal Examination

E. Ophthalmic

7. Key Associations — "WILLIAMS" Mnemonic

8. Age-Specific Presentation

9. Normal Values Relevant to Paediatric Assessment of Williams Syndrome

10. Growth and Development in Williams Syndrome

10.1 Growth

10.2 Development (Reference: CFB (PAE02) Child growth and development [4])

11. Family-Centred Care and Communication

12. Context within the GC Lecture: "The Malformed Child — Hereditary Syndromes and Anomalies"

Active Recall - Williams Syndrome (Definition, Epidemiology, Aetiology, Pathophysiology, Clinical Features)

References

Conceptual Framework: How to Think About the Differential

1. Differential Diagnosis by Presenting Feature

1A. The Dysmorphic Child with Intellectual Disability — Syndromic DDx

1B. Differential of Supravalvular Aortic Stenosis

1C. Differential of Hypercalcaemia in Infancy

1D. Differential of Short Stature / Failure to Thrive with Dysmorphic Features

1E. Differential of Developmental Delay with Overfriendliness / Behavioural Features

1F. Differential of Hypertension in a Child

2. Diagnostic Decision Algorithm — Pattern Recognition

3. Key Differentiating Points — "Calcium Clue"

4. Conditions that Share Individual Features with Williams Syndrome

5. Summary Table — Top 5 Syndromic DDx with Their Distinguishing Features

6. Approach to the Dysmorphic Child — Practical Clinical Strategy

Active Recall - Differential Diagnosis of Williams Syndrome

1. Diagnostic Criteria

1.1 Clinical Diagnostic Features (AAP / Williams Syndrome Association Consensus)

1.2 Formal Genetic Diagnostic Criterion

2. Diagnostic Algorithm

3. Investigation Modalities — Detailed Guide

3.1 Genetic / Confirmatory Investigations

3.2 Cardiovascular Investigations

3.3 Biochemical / Endocrine Investigations

3.4 Renal Investigations

3.5 Developmental and Neurocognitive Assessment

3.6 Audiological Assessment

3.7 Ophthalmological Assessment

3.8 Musculoskeletal / Other

4. Baseline Evaluation Protocol — What to Order at Diagnosis

5. Interpreting Key Investigation Results — Clinical Scenarios

Scenario A: "Echo shows narrowing above the aortic valve"

Scenario B: "Serum calcium 3.1 mmol/L in a 3-week-old with feeding difficulties"

Scenario C: "BP 130/85 in a 6-year-old with known Williams syndrome"

Scenario D: "FISH shows only 1 signal for ELN probe"

6. Why CMA Is Preferred Over FISH in 2025–2026 Practice

Active Recall - Diagnosis and Investigations of Williams Syndrome

1. Overarching Principles

2. Management Algorithm — Overview

3. Cardiovascular Management

3.1 Supravalvular Aortic Stenosis (SVAS)

3.2 Peripheral Pulmonary Stenosis (PPS)

3.3 Hypertension Management

3.4 Infective Endocarditis Prophylaxis